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ABSTRACT 
Uzoigwe, Jacinta C., Ph.D., Program of Biochemistry; College of Science and 
Mathematics, North Dakota State University, March 2011. Biochemical and 
Epidemiological Analysis of Mycohacterium avium Subspecies paratuherculosis and 
Investigation of its Relationship to Crohn's Disease in Humans. Major Professor: Prof. S. 
Derek Killilea. 
Background: Crohn's disease is a chronic inflammatory disease of the intestine in humans, 
with no known cause. Johne's disease is a chronic intestinal disease of ruminants caused by 
Mycohacterium avium suhspecies paratuherculosis (MAP), and has some features similar 
to Crohn's disease. Although MAP has been purported to play an etiologic role in Crohn's 
disease, this causal link is still under debate. Objective: The overall aim of this project is to 
analyze MAP strains from different hosts (cattle, sheep and humans) and regions in North 
Dakota by biochemical and epidemiological methods, in order to better understand the 
pathogenesis and epidemiology of MAP strains and the relationship between MAP and 
Crohn's disease. The specific aims of this research are the following: Aim 1. Investigate 
the epidemiological evidence for MAP as a cause of Crohn's disease. Aim 2. Conduct a 
comparative causality study to investigate whether MAP or other enteric pathogens cause 
Crohn's disease. Aim 3. Evaluate the occurrence of MAP infections in cattle in North 
Dakota, 1995-2005. Aim 4. Analyze MAP strains from symptomatic and asymptomatic 
cattle. Aim 5. Investigate the biochemical variations of rapid and slow growing MAP 
strains. Aim 6. Evaluate MAP strains from low shedders and high shedders. Methods: 
MAP isolates were analyzed by biochemical methods of gas chromatography, high 
performance liquid chromatography and mass spectrometry. In addition, extensive 
literature review was performed to ( 1) determine the epidemiologic causal link between 
MAP and Crohn' s disease and (2) determine whether MAP or other enteric pathogens 
Ill 
cause Crohn's disease. Results: Results from our study indicated the availablity of 
epidemiologic evidence supporting the causal role of MAP in Crohn's disease. It was also 
demonstrated that MAP is the most implicated organism in the etiology of Crohn's disease 
when compared to other infectious agents. Investigation of the occurrence of MAP 
infection in North Dakota showed an increase in number of MAP cases reported, with 
seasonal trends. Biochemical typing of MAP strains from symptomatic and asymptomatic 
cattle indicated that the symptoms status of isolates was significantly associated with mass 
spectra patterns and shedder status (p < 0.05). However, the association between symptoms 
status and HPLC and GC patterns was not significant (p > 0.05). Investigation of 
biochemical variations of rapid and slow growing MAP strains showed associations 
between the biochemical variability of MAP strains and their growth rate and presence of 
symptoms in the source cattle. Evaluation of MAP strains of different shedding 
characteristics by univariate logistic regression revealed that the shedder status of isolates 
was significantly associated with growth rate of isolates, symptom status, and source 
regions, but not with mass spectra patterns of isolates. Conclusion: Overall, this study 
strengthens the theories of strain sharing, intraspecies and interspecies transmission, and 
supports an association between MAP and Crohn's disease. In addition, the understanding 
of the biochemical variation among MAP isolates will help in the future design of 
diagnostics, therapeutics and vaccines for Johne's and Crohn's diseases. 
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GENERAL INTRODUCTION 
Mycobacterium paratuberculosis (MAP) causes a chronic inflammatory bowel 
disease in cattle and many other ruminant animals, referred to as Johne's disease (or 
paratuberculosis), which has many similarities with Crohn's disease. Crohn's disease is a 
chronic inflammatory disease of the gastrointestinal tract in humans. A controversial 
theory to date is the causal link between MAP and Crohn's disease. Despite the advances 
made in understanding human Crohn's disease, the etiology of this disease still remains 
unresolved. Clinically, Johne's disease is characterized by progressive weight loss leading 
to emaciation and often intermittent and constant diarrhea. It is reported that MAP is 
present in the milk, feces and meat of infected cattle. 
The cell wall lipid component of MAP strains has been analyzed by use of 
biochemical techniques. However, to fully understand the pathogenesis, virulence and 
epidemiology of MAP strains, as well as the association between Johne's disease and 
Crohn's disease, it is important that more research be geared toward understanding the 
biochemical profiles of MAP strains with different growth, symptom, and shedding 
characteristics. 
Our studies were divided into a number of sections that focused on epidemiological 
models of disease causation, the major philosophical doctrines about causation, the 
established epidemiological criteria for causation, and the currently known epidemiological 
evidence of M avium subsp. paratuberculosis as a possible cause of Crohn's disease. The 
several lines of evidence that determine whether MAP or other enteric pathogens cause 
Crohn's disease, was examined. The trends and risk factors for MAP shedding in cattle in 
North Dakota were evaluated. The characteristics of MAP ( e.g growth rate and shedding 
status) that contribute to their virulence and pathogenity were also investigated. 
Furthermore, the association between presence of symptoms and growth rate of MAP 
strain was examined. 
Overall, the data generated in our studies will improve our understanding of the 
differences in disease progression and pathogenicity of MAP isolates, as well as the 
relationship between MAP and Crohn's disease. These studies will also provide 
information that can be used to guide the future design of controls, diagnostics, 
therapeutics and vaccines for Johne's and Crohn's diseases. 
Explanation of the dissertation organization 
This dissertation consists of both biochemical and epidemiological studies and, is 
organized into six journal manuscripts. Paper I is a literature review of the epidemiological 
evidence for Mycobacterium avium subspecies paratuberculosis (MAP) as a cause of 
Crohn's disease. Paper 2 is another literature review that describes a comparative causality 
study of whether MAP or other enteric pathogens cause Crohn's disease. The remaining 
papers in this dissertation involve orginal research work, and each paper has its own 
introduction, materials and methods, results, discussion, conclusion and references. Paper 
3 examines the occurrence of MAP infection in cattle in North Dakota, 1995-2005. Paper 4 
describes the biochemical typing of MAP strains from symptomatic and asymptomatic 
cattle. Paper 5 investigates the biochemical variations of rapid and slow growing MAP 
strains. Paper 6 presents the analysis of MAP strains of different shedding characteristics. 
Finally, the general conclusions resulting from these studies are presented. 
2 
PAPER 1 
EPIDEMIOLOGICAL EVIDENCE FOR MYCOBACTERIUM 
AV/UM SUBSPECIES PARA TUBERCULOSIS AS A CAUSE 
OF CROHN'S DISEASE 
3 
ABSTRACT 
Mycobacterium avium subspecies paratuberculosis 1s the causative agent of 
Johne's disease, a chronic enteritis in ruminants including cattle, sheep, goats, and farmed 
deer. Recently, this bacterium has received an increasingly wide interest because of a 
rapidly growing body of scientific evidence which suggests that human infection with this 
microorganism may be causing some, and possibly all, cases of Crohn's disease. Recent 
studies have shown that a high percentage of people with Crohn's disease are infected with 
M avium subspecies paratuberculosis; whether the association of this bacterium and 
Crohn's disease is causal or coincidental is not known. Crohn's disease is a gastrointestinal 
disease in humans with similar histopathological findings to those observed in the 
paucibacillary form of Johne's disease in cattle. The search for risk factors in Crohn's 
disease has been frustrating. However, epidemiologists have gathered enough information 
that points to an association between M. avium subsp. paratuberculosis and Crohn's 
disease. This paper reviews epidemiological models of disease causation, the major 
philosophical doctrines about causation, the established epidemiological criteria for 
causation, and the currently known epidemiological evidence of M avium subsp. 
paratuberculosis as a possible cause of Crohn' s disease. 
4 
INTRODUCTION 
Mycobacterium avium subspecies paratuberculosis is a pathogenic bacteria in the 
genus Mycobacteria. It is often abbreviated as M paratuberculosis, M avium subsp. 
paratuberculosis or MAP. MAP causes paratuberculosis or Johne's disease, a chronic 
granulomatous gastroenteritis in ruminants (Harris and Lammerding). Johne's disease 
occurs worldwide and is primarily a disease of domesticated ruminants, including cattle 
(both beef and dairy), sheep, goats, and farmed deer (Tiwari et al. 2006; Kennedy and 
Benedictus, 2001). The host range for Johne's disease has been reported to include wild 
ruminant species, such as deer (Chiodini and Van Kruiningen, 1983; Buergelt and Ginn, 
2000; Cook et al. 1997; Manning et al. 2003), as well as non-ruminants, such as wild 
rabbits (Greig et al. 1997; Beared et al. 2001 a), their predators, including foxes and stoats 
(Beared et al. 2001b), and primates, such as mandrills and macaques (McClure et al. 1987; 
Zwick et al. 2000). The disease is characterized by profuse and intractable diarrhoea, 
severe weight loss and diagnostic changes in the lining of the small intestine (Grant, 1997; 
Collins et al. 2000). Crohn' s disease is a chronic inflammatory disease of the intestines in 
humans (Hanauer, 1996). The disease primarily causes ulcerations of the small and large 
intestines, although it can affect the digestive system anywhere from the mouth to the anus. 
Common symptoms of Crohn's disease include severe bouts of watery or bloody 
diarrhoea, cramping, abdominal pain, fever, weight loss, and bloating (Hanauer, 1996). 
Morphological changes in Crohn's disease include chronic inflammation involving all 
layers of the intestinal wall (transmural involvement), thickening of involved segments, 
with narrowing of lumen, linear ulceration of the mucosa, submucosa oedema with 
elevation of the surviving mucosa, producing a characteristic cobblestone appearance. 
5 
Crohn's disease in humans has long been suspected of having a mycobacterial cause 
(Harris and Lammerding, 200 l; El Zaatari et al. 2001; H ulten et al. 2000; Quirke, 200 l ). 
This proposition was first advanced by Dalziel, (1913 ). According to Clarke (1997), the 
histopathology of Johne 's disease ranges from the more common pluribacillary or 
lepromatous form to the less common paucibacillary or paucimicrobial tuberculoid form 
like leprosy in humans. Due to the histopathological features of Crohn's disease closely 
resembling those found in animals with the paucibacillary form of Johne's disease, it has 
been suggested that the two diseases shared the same aetiology (Grant, 1997; Collins, 
2000; Greenstein, 2003; Moss et a. 1992). The objectives of this paper were: (i) to review 
the epidemiological evidence involving the potential association of MAP with Crohn's 
disease in humans, and (ii) to determine if causation of Crohn's disease can be inferred 
based upon the evidence reviewed. 
Epidemiology of Johne's disease 
Mycobacterium avium subsp. paratuberculosis (MAP) is a member of the M avium 
complex (Thorel et al. 1990). M avium strains are widely distributed in the environment as 
well as in birds, animals, and humans (Hermon-Taylor, 2001; Primm et al. 2004; Wolinski 
and Rynearson, 1968). M avium strains do not usually cause disease unless the host is 
debilitated or immunocompromised. By contrast MAP is a specific pathogen with the 
ability to cause chronic inflammation of the intestine (Johne's disease) in many species 
(Chiodini et al. 1984; Cocito et al. 1994; Harris and Barletta, 2001; Manning and Collins, 
2001). MAP is a well recognized cause of disease and economic loss in dairy herds, and 
most control programmes have been designed for the dairy industry (Goodger et al. 1996; 
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Johnson-lferulundu and Kanneene, 1999). It is estimated that nearly 40% of United States 
dairy herds are infected with MAP and that losses to the dairy industry may exceed $1.5 
billion per year (Jones, 1989; Stabel, 1998). MAP is most commonly transmitted via the 
faecal-oral route (USDA, 1999; Reed et al. 2006). However, it can also be transmitted in 
the semen of bulls, in milk (or colostrum), and in utero across the placenta to the newborn 
calf (Tiwari et al. 2006). Moreover, it has been suggested that MAP can exist within the 
tissues of animals for years without causing clinical disease ( Cetinkaya et al. 1996). 
Subclinically or clinically infected animals shed MAP in faeces and milk, enabling 
dissemination to susceptible calves, the environment, and in retail milk (Millar et al. 1996). 
MAP in milk may survive pasteurization (Millar et al. 1996). In the United Kingdom, the 
United States, and the Czech Republic, MAP has been cultured from 1.6% to 2.8% of units 
of retail pasteurized cow's milk (Millar et al. 1996; Grant et al. 2002; Ayele et al. 2005; 
Ellingson et al. 2005), and it has been suggested that live organisms might be transmitted 
to humans by this route. 
Epidemiology of Crohn's disease 
Crohn's disease occurs throughout the world, with a prevalence of 161-319 
cases/100 000 people in Canada (Bernstein et al. 2006). It is most prevalent in Europe and 
North America (Scientific Committee on Animal Health and Animal Welfare, 2000). The 
disease affects between 400 000 and 600 000 people in North America alone (Loftus et al. 
2002). Prevelance estimates for Northern Europe have ranged from 27-48/100 000 
(Bernstein et al. 2006). The incidence of Crohn's disease in North America has been 
estimated at 6/100 000 per year, and is thought to be similar in Europe, but lower in Asia 
7 
and Africa (Hatt and Kaufman, 1988; Mourn et al. 1996). The incidence of Crohn's disease 
in industrialized parts of the world has been reported to be increasing (Calkins and 
Mendelofff, 1986; Loftus et al. 1998; Hermon-Taylor et al. 1994; Armitage et al. 2001 ). 
The disorder occurs most frequently among people of European origin, is 3-8 times more 
common among Jews than among non-Jews (Podolsky, 2002). However, this excess risk is 
not evident in the Jewish population of Israel (Niv et al. 1999). Although the disorder can 
begin at any age, its onset most often occurs between 15 and 30 years of age (Loftus, 2004; 
Card et al. 2003; Shivananda et al. 1996; Lapidus et al. 1997). Satsangi et al. ( 1997) 
reported that parents, siblings or children of people with Crohn' s disease were 3-20 times 
more likely to develop the disease than the general population. Twin studies show a 
concordance of greater than 55% for Crohn's disease (Tysk et al. 1988; Orholm et al. 
2000; Thompson et al. 1996). Mutations in a gene called NOD2/CARD15 are associated 
with Crohn's disease (Ogura et al. 200 l; Fielding, 1986; van Heel, 2000), and with 
susceptibility to certain phenotypes of disease location and activity (Cuthbert et al. 2002 ). 
The NOD2/CARD15 susceptibility does not apply to Chinese (Leong et al. 2003 ), 
Japanese (Inoue et al. 2002), Korean (Lee et al. 2005), Tunisian (Zouten-Mekki et al. 
2005) or Turkish (Uyar et al. 2006) patients with Crohn's disease. A susceptibility locus 
for Crohn's disease has been mapped to chromosome 16 (Hugot et al. 2001). Three 
independent studies reported that mutations within the NOD2/CARD 15 gene were strongly 
linked to Crohn's disease in Europeans (Ogura et al. 2001; Hugot et al. 2001; Hampe et al. 
2001). However, Greenstein (2003) reported that the presence of a gene that is associated 
with an increased susceptibility to Crohn' s disease does not preclude the possibility that 
the disease may be caused by an infectious agent. Another study (Inoue et al. 2002), 
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suggested the possibility of genetically identifiable subpopulations having different 
tendencies to develop Crohn' s disease when exposed to the same infectious agent. Recent 
studies have identified an association between inflammatory bowel disease (IBD) and 
mutations in yet another gene termed NRAMP1 (also known as SLC11 A 1) (Kojima et al. 
2001 ). This gene has been reported to be associated with both Crohn' s disease and 
ulcerative colitis. 
Epidemiological models for causation 
Epidemiology is the scientific inquiry into the causation of disease; it is the search 
for the risk factors that cause the effect or the disease (Parascandola and Weed, 2001 ). In 
this search, various models or theories for causation have been developed over the years in 
an attempt to explain the interaction of risk factors and their effect on disease; Models are 
purposely simplified representations of that interaction (Rothman and Greenland, 2005 ). 
The various models of causation include: epidemiological triad/triangle (Last, 2001; 
Torrrence, 1997), web of causation (Krieger, 1994 ), wheel of causation (Mausner and 
Bahn, 1986) and Rothman's causal pie (Rothman and Greenland, 2005). 
Epidemiological triangle/triad 
This model makes the agent a component of causation along with the host and 
environment (Fig. 1.1 ). The model implies that all components are equally important in 
disease causation and that a change in any one of them would change the frequency of 
disease. The model applies to both infectious or noninfectious diseases. For instance, in 
Johne's disease the agent would be the bacterium, MAP; host factors include non-immune, 
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weakened resistance, poor nutrition, age, gender; and environmental factors include animal 
stocking density, poor environmental conditions (such as temperature, humidity, wind 
velocity, precipitation, poor housing as in crowded conditions, poor ventilation, and bad 
sanitation). 
Agent 
Figure 1.1: Epidemiological triangle/triad (Torrence, 1997). 
Wheel of causation 
The wheel model places genetic factors in the core of the wheel and varies the size 
of the host and environmental components depending on their influence in the particular 
disease process (Krieger, 1994). Surrounding the host is the total environment divided into 
the biological, physical, and social environments (Fig. 1.2). These divisions, of course, are 
not true divisions -there are considerable interactions among the environment types. 
Although it is a general model, the wheel of causation does illustrate the multiple 
aetiological factors of human infectious diseases (Mausner and Bahn, 1986). According to 
Jantchou et al. (2006), many environmental factors for IBO have been investigated, 
including infectious agents, diet, drugs, stress and social status. Among these factors, 
MAP, oral contraceptives and antibiotics could play a role in Crohn's disease (Jantchou et 
al. 2006; Sicilia, 200 I; Chiodini and Rossiter, 1996: Dumonceau et al. 1996; El Zaatari et 
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al. 1995). Sicilia et al. (200 l) reported that the pathogenesis of IBD probably involves an 
interaction between genetic and environmental factors: cigarette smoking, appendectomy 
and oral contraceptives are the factors most frequently linked to its aetiology. 
Biolo~i\.'.al 
l.'n ,. iron nh.'nl 
Phy-.il.·al 
t'II\ lflllllllelll 
Figure 1.2: Wheel of causation (Mausner and Bahn, 1986 ). 
Web of causation 
Social 
t'Jl\'irtllllllt'lll 
This model refers to the 'web' of interconnected factors which lead to disease. The 
web of causation merely reflects the fact that there is a complex mixture or a 'web' of 
factors that can cause disease (Krieger, 1994 ). Many aetiological factors for Crohn's 
disease have been suggested, including autoimmune, genetic, dietary components plus 
various infectious agents including MAP (Chiodini and Rossiter, 1996; Dumonceau et al. 
1996; El Zaatari et al. 1995). 
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Causal pie model 
The main causal model used by epidemiologists today is Rothman's 'pies' 
(Rothman and Greenland, 2005). The idea is that a sufficient causal complex (a pie) is 
represented by the combination of several component causes (slices of the pie) (Fig. 1.3). 
A set of component causes occurring together may complete the 'pie ', creating a sufficient 
cause and thus initiating the disease process. Rothman and Greenland (2005) define both 
'necessary' cause and 'sufficient' cause. A ·sufficient' cause is one that always results in 
disease (Rothman and Greenland, 2005 ), while a 'necessary' cause is one that must be 
present but might not be the cause of a disease to develop. In other words, a necessary 
cause is a component cause that is a member of every sufficient cause (Timmreck, 2002; 
Greenland, 1987; Gordis, 2000; Elwood, 1988; Lilienfeld and Stolley, 1994; Last, 1988; 
Kleinbaum et al. 1982). Rothman (1982) defines 'a cause of a disease event as an event, 
condition, or characteristic that preceded the disease event and without which the disease 
event either would not have occurred at all or would not have occurred until a later time'. 
If disease does not develop without the factor being present, then the causative factor is 
termed 'necessary'. If the disease always results from the factor, then the causative factor 
is termed 'sufficient'. In reference to Rothman's causal pie model, the possibility exists 
that MAP is a 'necessary' but not a 'sufficient' cause of Crohn's disease. As a necessary 
cause, MAP is required to be present to trigger the inflammatory reaction seen in Crohn's 
disease. However, not being a sufficient cause means that MAP cannot cause Crohn's 
disease alone but acts in concert with immune dysfunction and genetic susceptibility in 
order for Crohn's disease to occur (Chiodini and Rossiter, 1996; El Zaatari et al. 1995). 
Therefore, not every one with the presence of MAP in the intestine would suffer from 
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Crohn's disease. Moreover, the failure to detect MAP in some cases of Crohn's disease 
may not necessarily indicate that MAP is absent. Low specificity and sensitivity of the test, 
among other factors, may explain the inability to detect MAP in some patients (Jeyenathan 
et al. 2006). It has been reported that the sensitivity of nucleic-acid based tests is 
influenced by the bacterial burden, as exemplified by the compromised sensitivity of PCR-
based assays for sputum smear-negative tuberculosis (Forbes, 1997; !even and Goossens, 
1997; Noordhoek et al. 2004). By extension, assays that reliably detect abundant MAP 
organisms in livestock with Johne' s disease may not provide sufficient sensitivity to study 
human Crohn's disease (Jeyenathan et al. 1994). 
Figure 1.3: Causal pie model (Rothman and Greenland, 1998). This illustration shows a 
disease that has three sufficient causal complexes, each having five component causes. A is 
a necessary cause since it appears as a member of each sufficient cause. B. C, and F are not 
necessary since they fail to appear in all three sufficient causes. 
The major philosophical doctrines about causation 
The two major philosophical doctrines that have influenced modem science include 
inductivism and refutationism. 
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Inductivism 
This doctrine holds that science proceeds from observation to theory, beginning 
with observations derived from experiments. and extrapolating from these to general laws 
(Last, 2001; Weed and Gorelic, 1996; Susser, 1991; Rychetnik et al. 2004; Bernard, 1949; 
Bacon, 1994 ). Bacon's vision of the 'true induction· comprises three interrelated stages: 
(i): Observation and Experiment (ii) Classification and Concept Formation and (iii) 
Eliminative Induction and Causal Inference (Bacon, 1994). The traditional view of science 
is that induction - the formation of a hypothesis based on observation - is cardinal to the 
scientific method. However, Hume ( 1978 ), the deductivists and others (Hendel, 1955) 
argued that a hypothesis that is derived by induction is flawed because it can be refuted by 
the first observation that proves an exception. Deduction refers to reasoning that proceeds 
from the general to the particular and relies on general theory to infer particular 
conclusions (Last, 2001 ). A century after Hume, Mill (1950a) proposed a canon of five 
methods to infer causes from their effects incorporating some of the ideas that had been 
proposed earlier by Bacon (193 7). The canons of Mill (1950b) have evolved into 
inferential criteria that are in use today. 
Refutationism or falsificationism 
This theory is a rival account of the processes involved in scientific research to 
inductivism. While inductivism holds that science proceeds from observation to theory, 
beginning with observations derived from experiments, and extrapolating from these to 
general laws, falsificationism suggests that science proceeds in the opposite direction, 
beginning with scientific theories or 'conjectures', and then conducting experiments and 
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eliminating those theories that are falsified by results (Rothman, 1988; Pearce and 
Crawford-Brown, 1989; Kuhn, 1970; Susser, 1988). Karl Popper, one of the most 
influential philosophers of science of the twentieth century (Susser, 1986 ), followed Hume 
in rejecting induction, claiming that it is always possible to produce a theory to fit any set 
of observations (Buck, 1975). According to Karl Popper 'Our belief in a hypothesis can 
have no stronger basis than our repeated unsuccessful critical attempts to refute it' (Popper, 
1972). Popper and other scientists believed that causation is established through a process 
of conjecture and refutation, and that science advances only by disproofs (Buck, 1975; 
Page et al. 2003; Platt, 1964). Popper insisted strictly on deduction, allowing the sole 
capability of science to be the falsification of prior hypotheses (the so-called hypothetico-
deductive method), rejecting any place for verification (Rothman, 1988). 
Relationship between association and causation 
Association is an identifiable relationship between an exposure and disease. 
Association implies that exposure might cause disease (Rothman and Greenland, 2005; 
Krieger, 1994). Epidemiologists infer causation based upon the association and several 
other factors (Jantchou et al. 2006; Sicilia et al. 2001; Chiodini and Rossiter, 1996). 
Causation implies that there is a true mechanism that leads from exposure to disease 
(Torrence, 1997; Jantchou et al. 2006; Chiodini and Rossiter, 1996; Vineis and Kriebel, 
2006; Gordis, 2004; Rothman, 2002; Kundi, 2006). However, the presence of an 
association does not necessarily mean that the relationship is causal (Parascandola and 
Weed, 2001; Torrence, 1997; Chiodini and Rossiter, 1996). 
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Deriving causal inferences 
The variation among the viewpoints of epidemiologists with regard to causality is 
rooted in the variation among philosophical viewpoints. However, Hill's criteria provide 
interpretive guidelines for evaluating epidemiological evidence. Hill established the 
following classic operational causal criteria: strength of association, consistency, 
specificity, temporality, biological plausibility, dose-response effect, coherence, 
experimental evidence, and analogy (Hill, 1965; Hill, 1971; Hofler, 2005; Phillips and 
Goodman, 2001 ). According to Hill (1965 ), not all of these guidelines will be applicable in 
all situations and that there may be times when we wish to conclude that a putative cause-
effect relationship is real even when some of the criteria are not met. According to 
Rothman (1986), only the criterion of temporality is a sine qua non for causality. If the 
putative cause did not precede the effect, that indeed is indisputable evidence that the 
observed association is not causal. Other than that one condition, there is no necessary or 
sufficient criterion for determining whether an observed association is causal (Rothman, 
1986). This conclusion is in accordance with the view of Hume, Popper, and others that 
causal inferences cannot attain the certainty of logical deductions (Hume, 1978; Kuhn, 
1970; Susser, 1988). There is no explicit consensus about what constitutes sufficient 
evidence to establish causation from association. 
Established epidemiological criteria for causation 
The established epidemiological criteria for causation are meant to be guidelines in 
assisting judgement as to whether an association is causal or not. Criteria of causation refer 
to a set of criteria used to assess the strength of a relation between a cause and an effect, 
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and provide a way ofreaching jugdements on the likelihood of an association being causal. 
The most widely cited list of causal criteria, originally posed as a list of standards, is 
attributed to Hill (1965), who adapted them from the U.S. Surgeon General's 1964 report 
on smoking and health (United States Department of Health, Education and Welfare, 
1964). Most of these lists stem from the canons of inference described by Mill (1950b) and 
the rules given by Hume (1978). The widely adopted criteria that have been refined by 
several scientists (Torrence, 1997; Krieger, 1994; Pearce and Crawford-Brown, 1989, 
Susser, 1986; Fletcher et al. 1996) include: (i) strength of association; (ii) consistency of 
effect; (iii) specificity of effect; (iv) temporality; (v) biological gradient or dose response; 
(vi) biological plausibility. 
Strength of association 
Strength of association refers to the extent to which a supposed cause and effect are 
related and should not be confused with statistical significance (Pearce and Crawford-
Brown, 1989). The most common measure of strength of association is relative risk or rate 
ratio (Pearce and Crawford-Brown, 1989). Other measures of association in epidemiology 
include the odds ratio, a correlation coefficient and attributable risk (Pearce and Crawford-
Brown, 1989). According to Chamberlin et al. (Chamberlin et al. 2001 ), technical advances 
have allowed the identification and/or isolation of MAP from a significantly higher 
proportion of Crohn's disease tissues than from controls. These methodologies include: (i) 
improved culture techniques; (ii) development of MAP-specific polymerase chain reaction 
assays; (iii) development of a novel in situ hybridization method; (iv) efficacy of macrolide 
and anti-mycobacterial drug therapies; and (v) discovery of Crohn's disease-specific 
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seroreactivity against two specific MAP recombinant antigens (Chamberlin et al. 2001 ). 
Several studies (Naser et al. 2004; Mishina et al. 1996) reported that 50% of Crohn's 
disease patients and 22% of ulcerative colitis patients were MAP positive and MAP was 
not cultured from the non-IBO patients. Some researchers suggest that all of inflammatory 
bowel disease (IBO) may be due to MAP (Naser et al. 2004; Mishina et al. 1996). Chiodini 
et al. (1984), described the isolation of a slow-growing, mycobactin-dependent 
Mycobacteria species from the intestinal mucosa of Crohn 's disease patients but not from 
control tissue. 
Consistency of effect 
This epidemiological criteria refers to the fact that an association is found in many 
studies despite different circumstances, research designs, or time-periods (Krieger, 1994 ). 
Relationships that are demonstrated in multiple studies are more likely to be causal than 
those that are not. Several studies conducted at different times by different research 
methods have reported on the isolation of MAP from patients with Crohn' s disease 
(Chamberlin et al. 200 I; Hermon-Taylor et al. 2000; Hui ten et al. 2001; Ikonomopoulos et 
al. 2000; McFadden et al. 1987; Sechi et al. 2005; Sechi et al. 2001). MAP has been found 
in Crohn's disease patients by genetic probes (including both DNA, and RNA) (Jeyenathan 
et al. 2006). The insertion element IS900, found at 14 to 18 copies per genome has been 
shown to be genomically specific for MAP (Sechi et al. 200 I) and, has been widely used 
as a target for PCR (Chamberlin et al. 2001; Mishina et al. 1996; Turenne et al. 2006; 
Autschbach et al. 2005; Bull et al. 2000; Bull et al. 2003; Chiodini et al. 1986; Hermon-
Taylor et al. 1990; Moss et al. 1991; Ryan et al. 2002). 
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Specificity of effect 
Specificity describes the precision with which a factor will predict the occurrence 
of a specific disease; it adds plausibility to the causal claim but, if absent, does not detract 
from it (Susser, 1988). Routine culture of MAP from Crohn' s disease patients· tissues is 
difficult because when present MAP is commonly in spheroplast form (cell wall deficient), 
which does not thrive in standard culture conditions (Chamberlin et al. 2001; Chiodini et 
al. 1986). It has also proved difficult to detect MAP in Crohn · s disease tissues by other 
methods: the mycobacterial cell wall Ziehl-Neelsen (ZN) staining techniques, first 
described in 1882 (Ziehl, 1882; Neelsen, 1883) have not shown MAP in humans because 
MAP exists in the cell-wall-deficient form (Greenstein, 2003); serology studies have been 
beset by problems of nonspecificity because of antigen cross reactivity (Fiocchi, 1998), 
although more recent studies have reported a specific high immune reactivity to 
recombinant MAP antigens in Crohn's patients (Naser et al. 1999; EI-Zaatari et al. 1999). 
These difficulties reflect the fact that MAP microorganisms when present in Crohn's 
disease are few in number, relative to bovine cases of MAP infection (Johne's disease) 
(Sanderson et al. 1992). An assay for MAP in Crohn's disease must be able to specifically 
detect small numbers of organsisms with tissue, near or below the threshold of microscopic 
detection (Jeyenathan et al. 2006). Molecular methods have been used to determine the 
prevalence of MAP in cases of Crohn's disease (McDonald, 2001). An important 
limitation of studies looking for novel pathogens is that information about the sensitivity 
and specificity of assays applied is generally lacking (Jeyenathan et al. 2006 ). In separate 
studies, it has been shown that IS900 element is genomically specific for MAP (Turenne et 
al. 2006) and that IS900 sequences from a heterogenous collection of MAP are invariant 
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(Semret et al. 2006). According to Sechi et al. (2001 ), MAP has been identified by in situ 
hybridization to the MAP-specific IS900 gene in tissue specimens of Crohn 's disease. 
However, despite these favourable considerations, the IS900-based in situ probe was prone 
to non-specific hybridization, compromising the utility of IS900-based in situ hybridization 
and indirect in situ PCR (St. Amand et al. 2005 ). Jeyanathan et al. (2006 ), reported that the 
alternative means of increasing specificity and sensitivity involves the use of rRNA-
specific oligonucleotide probe in situ hybridization. Probes targeting rRNA provided 
excellent specificity resulting in forms that were morphologically consistent with ZN-
positive organisms on adjacent sections. Ryan et al. (2002), reported the detection of MAP 
DNA in 40% of Crohn's cases where microdissected granulomas were examined. 
However, only half of the granuloma positive cases had corresponding whole tissue 
sections that were positive for MAP. The greater detection rate of MAP in laser capture 
microdissection (LCM) isolated granulomas compared with whole tissue sections may 
have been attributable to better targeting of MAP DNA in granulomas - PCR may suffer 
loss of sensitivity because of the potential dilutional effect of the large quantities of non-
target DNA found in whole tissue sections. Failure to detect MAP in some studies may 
have been attributable to inefficient amplification of long sequences (>250 bp) (Riggio et 
al. 1997). 
Temporality 
Temporality refers to the necessity that the cause precedes the effect in time 
(Fletcher et al. 1996). Causation is not possible without the cause occurring before the 
effect (Rothman, 1982). Data exist that indicate that temporal sequence criteria have been 
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fulfilled for the association between Crohn' s disease and MAP (Van Kruiningen et al. 
1986; Van Kruiningen et al. 1991 ). In a study by Van Kruiningen et al. (1986), a goat was 
infected with MAP organism taken from a human patient with Crohn's disease and showed 
progression to Johne's disease. A 1991 report found that 24-day-old specific pathogen-free 
Leghorn-Cochin chicks could be infected by multiple exposure routes using the same MAP 
strain ('Linda') (Van Kruiningen et al. 1991 ). 
Dose-response relationship 
A dose-response effect is present when the effect increases with the dose or level 
of exposure. In a study conducted by Schwartz et al. (2000), the intestinal mucosa! layer 
from patients with IBO had high numbers of bacteria compared with people without 
Crohn's disease, however, there was no correlation between the numbers of bacteria 
present and either the degree of inflammation or the use of anti-inflammatory agents or 
sulfasalazine compounds (Schwartz et al. 2000). This study suggests that a demonstration 
of dose-response criterion may not be applicable to a relationship between MAP and 
Crohn's disease. The pivotal event that convinced a totally skeptical gastroenterological 
community to accept that Helicohacter pylori was the aetiological factor in peptic ulcers 
was the cure rate that was achieved when the putative H. pylori infection was treated with 
appropriate antibiotics (Greenstein, 2003 ). Similarly, Greenstein (2003) suggested that the 
failure to cure IBD with anti-MAP antibiotics is the main impediment to convincing a 
sceptical gastroenterological community that MAP is zoonotic. Possible reasons that could 
account for this inability to cure patients with Crohn's disease include, the use of the 
wrong antibiotics and lack of satisfactory perfonned studies that are prospective, 
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randomized, double blinded and placebo controlled, that have been performed usmg 
acknowledged satisfactory anti-MAP antibiotics (Greenstein, 2003 ). Recently, Greenstein 
et al. (2007), demonstrated that methotrexate and 6-mercaptopurine inhibit MAP growth in 
vitro. However, the dosages of methotrexate and 6-mercaptopurine in clinical use have not 
been titrated according to standard antibiotic conventions (Greenstein et al. 2007). 
Biological plausibility 
A hypothesized effect is biologically plausible if it makes sense in the context of 
current biological knowledge (Rothman and Greenland, 2005). By the 1930s, Johne's 
disease was found to be caused by an odd bacteria named Mycohacteria paratuberculosis. 
This organism is from the same family of bacteria which cause tuberculosis and leprosy. 
Current concepts regarding the cause of Crohn' s disease emphasize a dysfunction of the 
immune system resulting in a prolonged and intense process of inflammation (Danze et al. 
1996; Hodgson, 1998; Sartor, 1995; Strober and Neurath, 1996; Van Hogezand and 
Verspaget, 1996). The damage to the bowel appears to be due to this inflammatory process 
(Sartor, 1995; Strober and Neurath, 1996; Van Hogezand and Verspaget, 1996 ). MAP is 
thought to produce disease by over-stimulating the immune system. The bacterium lives 
inside the cells of the host, where it divides only once about every 2-12 h. By way of 
contrast, other bacteria in the gut such as Escherichia coli, Salmonella .\pp., Shigella spp., 
divide about once every 20 min. There are no toxins or poisons produced by MAP. Disease 
happens when the immune system recognizes the 'foreign' proteins of the bacteria, even 
inside a living cell and mounts a furious attack (Danze et al. 1996; Hodgson, 1998; Sartor, 
1995). The immune 'attack' focuses on the infected cells in the mucosal layer of the 
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digestive system and results in massive inflammation, as well as ulcers, diarrhoea and 
weight loss (Schwartz et al. 2000; Danze et al. 1996; Hodgson, 1998; Sartor, 1995). 
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CONCLUSION 
This paper has attempted to highlight current scientific evidence in regard to 
fulfilling the epidemiological criteria for a causal association between MAP and Crohn's 
disease. We were able to demonstrate that data exist that show that the MAP Crohn's 
disease phenomenon has fulfilled at least four (strength of association, consistency of 
effect, temporality and biological plausibility) of the six epidemiological causal criteria 
outlined by Hill. In summary, the current epidemiological evidence strongly supports the 
conjecture that Crohn's disease is caused by MAP especially for those who believe in the 
theory of inductivism. Several studies that demonstrated scientific evidence, including 
temporality, necessary to infer a causal association between MAP and Crohn's disease 
were highlighted. For the followers of Popper who believe in falsification/deductivism, 
whether enough observations or experiments have been conducted to falsify the 
MAP/Crohn's disease phenomenon is a matter of personal judgement. Moreover, there are 
people who believe that studies can falsify a theory only to a certain degree. 
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PAPER2 
DOES MYCOBACTERIUM A VJUM SUBSPECIES 
PARATUBERCULOSIS OR OTHER ENTERIC PATHOGENS 
CAUSE CROHN'S DISEASE? A COMPARATIVE 
CAUSALITY STUDY 
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ABSTRACT 
Crohn's disease is defined as a chronic inflammatory disease of the intestine in humans 
characterized by transmural inflammation and formation of granuloma. Despite decades of 
research work, the exact cause of Crohn·s disease has not been identified. It is proven that 
Crohn's disease is genetic; however. there are several lines of evidence that suggests that 
Crohn's disease also has a microbial element. Therefore, an important question is which 
microbes would have a role in the etiopathogenesis of Crohn·s disease. Broadly, there are 
two groups of organisms considered: ( I ) normal flora and (2) pathogens, such as 
Mycobacterium avium subspecies paratuherculosis (MAP). Adherent-invasive Escherichia 
coli (AIEC), Listeria monocytogenes, Yersinia .\pecies, Herpesviruses, Measles virus, and 
Norovirus. We were interested in determining whether any of these candidates has met any 
or some of the criteria set by Rothman and others for causality. In a previous study, we 
conducted an extensive review of epidemiologic evidence of MAP as a cause of Crohn's 
disease. In the present study, we ask the question of whether there is epidemiologic 
evidence which supports other enteric microbes as possible causes of Crohn's disease. The 
answer to the question was obtained by subjecting other intestinal microbes to the same 
treatment applied to MAP. While MAP fulfilled 4 criteria, other intestinal pathogens 
fulfilled less than 4 of the established epidemiological criteria. In general, this study 
supported and strenghtened the hypothesis that MAP is the most commonly implicated 
organism in the etiology of Crohn·s disease. The study provided a better understanding of 
the causal roles of microbes in Crohn ·s disease, and would help to provide better 
therapeutic interventions. 
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INTRODUCTION 
Crohn's disease is recognized as a chronic inflammation of the wall of the intestine 
in humans (Dalziel, 1913; Greenstein. 2003 ). Together, Crohn's disease and ulcerative 
colitis are known as inflammatory bowel disease (Hanauer, 1996 ). Crohn 's disease can 
affect any area of the gastrointestinal tract from the mouth to the anus, but it most often 
begins at the terminal ileum, the junction between the small intestine and the large 
intestine. The disease, most commonly diagnosed in people between the ages of 20 and 30, 
is characterized by periods of active inflammation, called flare-ups, and periods of reduced 
or absent symptoms, called remission. All layers of the intestine may be involved in 
Crohn's disease as the inflammation often spreads deep into the layers of affected tissues, 
and normal healthy intestine can be found between sections of diseased bowel. The 
inflammation can lead to various symptoms of Crohn's disease, which most commonly 
include chronic diarrhea, abdominal pain, weight loss, fatigue and fever (l lanauer, 1996; 
Hanauer and Meyers, 1997). It is reported that some people with Crohn's disease also have 
problems outside of the gastrointestinal tract that may include inflammation of the eyes, 
skin, or joints, and liver problems (Hanauer and Meyers, 1997; Wagtmans et al. 1997). 
Under normal situations, the immune response in human intestine is characterized by a 
balance between pro-inflammatory and anti-inflammatory factors. In patients with Crohn's 
disease, the balance between these two factors in the intestinal mucosa is altered, thereby 
shifting the normal equilibrium toward a chronic inflammatory state. It is reported that 
once the cascade of inflammation begins, most of the subsequent pathophysiologic events 
are related (van Deventer, 1999; Hanauer et al. 1998; Sands, 2000). Many studies (van 
Deventer, 1999; Hanauer et al. 1998; Sands. 2000) have shown that the inflammatory 
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process in Crohn's disease is characterized by increased production of pro-inflammatory 
cytokines, especially tumor necrosis factor (TNF-alpha). Investigators reported that TNF-
alpha is present in excess in the mucosa of patients with Crohn's disease, and that increases 
in TNF-alpha are associated with the release of other pro-inflammatory cytokines, such as 
interleukin 1, 6, and 8 (Hanauer et al. 1998 ). In Crohn' s disease, the ongoing (chronic) 
intestinal inflammation may lead to complications (e.g intestinal strictures and fistulas) and 
may necessitate the removal of sections of intestine (I lanauer et al. 1998 ). It is known that 
inflammation is part of the body's immune response, and an immune response is usually 
triggered by antigens. Up to date, no specific trigger has been found to cause the 
inflammatory response seen in Crohn's disease. Thus, despite decades of relevant research, 
the exact cause of Crohn's disease is still unknown. 
Several theories regarding the cause of Crohn's disease have been purported, but 
research has never confirmed a specific causal agent. There is substantial evidence that 
Crohn's disease has a genetic component. According to investigators, at least 30 distinct 
genes have been identified to influence the risk of developing Crohn's disease, including 
but not limited to genes involved in innate pattern recognition receptors ( e.g. 
NOD2/CARD15, TLR4, CAR09), autophagy (e.g ATG16LI, IRGM, LRRK2), 
maintenance of mucosa] integrity integrity (1805, DLG5, PTGER4, ITLN 1, DMBTI, 
XBPI) and the promotion of the secondary immune response (HLA-region, 
TNFSFIS/TLIA, IRFS, PTPN2, PTPN22, NKX2-3, IL-128, IL-18RAP, MSTl (Van 
Limbergen et al. 2009). The first Crohn ·s disease susceptibility gene identified was a gene 
known as the caspase recruitment domain (CARD) 15 gene, which encodes the nucleotide 
oligomerisation domain (NOD) 2 receptor, a pattern recognition receptor (Hugot et al. 
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2001; Ogura et al. 2001). Studies have shown that the NOD2/CARDl5 protein is an 
intracytoplasmic receptor that binds bacterial peptidoglycan-derivcd muramyl dipeptide via 
its leucin-rich repeat (LRR) region (I no hara et al. 2003; I no hara and N uncz, 200 I). It is 
reported that mutations in CARDI 5 gene lead to defective recognition of muramyl 
dipeptide and a decreased clearance of intestinal bacteria (lnohara ct al. 2003; Inohara and 
Nunez, 2001). Investigators have shown that autophagy plays a role in innate immunity 
and eliminates pathogens in vitro and in vivo, but when abberant as a result of mutations, 
contributes to chronic inflammatory diseases such as Crohn's disease (Delgado et al. 2009). 
Sanders (2005) demonstrated the presence of Crohn's-like lesions after compromise of 
mucosal integrity in the presence of an intact immune system, through altered expression 
of mucosal adhesion molecules, such as cadherins and tight junction proteins, which 
highlights the importance of the mucosa) barrier in the development of Crohn's disease. 
Van de Vosse and Ottenhoff (2006) showed that mutations in / L-12 B impair I L-12 and IL-
23 responses and predispose individuals to infections caused by mycobacteria and 
salmonella. 
It is clear that Crohn's disease has a genetic component. However, the mutation in 
Crohn's disease genes alone is not enough to trigger Crohn's disease. Specific triggering 
agents are just as important, including microbial or other environmental factors. 
Investigators have shown that various environmental factors may be involved in the 
development of Crohn's disease, but microbes are most consistently implied (Hertogh et 
al. 2008). Numerous studies indicated that bacteria from the intestinal lumen seem to be 
important in the development of mucosa! inflammation in Crohn' s disease patients. The 
two main hypotheses on the etiopathogenesis of Crohn ·s disease focus on whether (i) the 
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normal intestinal microflora are responsible for Crohn's disease by acting as a persistent 
antigenic stimulus in genetically susceptible hosts (Sartor, 1997), or (ii) that there is an as 
yet unidentified specific microbial pathogen causing Crohn's disease (Blaser, 1997). There 
are several lines of evidence that suggests that Crohn' s also has a microbial element. These 
include: (i) most people with variants of Crohn's genes do not get Crohn's (Hugot, 2007); 
(ii) animals knocked out for Crohn·s susceptibility genes, such as NOD2, do not have 
bowel disease (Wehkamp, 2005); (iii) most Crohn's susceptibility genes encode proteins 
responsible for innate immunity to bacteria (Parkes, 2007); and (iv) observed clinical 
benefit with antibiotic treatment (Selby, 2007). Therefore, an essential question is which 
microbes would have a role in the etiology and pathogenesis of Crohn' s disease. Generally 
in this study, there are two categories of organisms considered: ( 1) normal flora and (2) 
pathogens, such as MAP, AIEC, Listeria monocytoKenes, Yersinia enterocolitica, 
herpesviruses, measles virus and norovirus. We were interested in investigating whether 
any of these candidates has met any or some of the criteria set by Rothman and others for 
causality. 
Comparison of common microbes implicated in etiopathogenesis of Crohn's disease 
using the established epidemiological criteria for causation 
The established epidemiologic criteria are recognized as a set of criteria that serve 
as a guideline in the determining whether an association is causal or not (Hill, 1965 ). It is 
reported that, in theory, causal criteria could be used to either refute or predict causal 
effects (Weed, 1997). There are widely adopted criteria, which have been refined by 
several scientists (Hill, 1965: Torrence, 1997: Fletcher et al. 1996) that include: (i) 
consistency of effect; (ii) biological plausibility; (iii) strength of association; (iv) 
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temporality; (v) specificity of effect; and (vi) biological gradient or dose response. The 
criteria of "consistency of effect" describes the fact that if similar associations are found in 
different studies in different populations. the more likely the causal role of the factor. For 
the criteria of biological plausibility. association between the risk factor and the outcome is 
biologically plausible if it makes sense in the context of current biological knowledge 
(Rothman and Greenland, 2005 ). The criteria ··strength of association .. refers to the extent 
to which a supposed cause and effect are related. The larger the relative effect, the more 
likely the causal role of the factor (Pearce and Crawford-Brown. 1989). One of the ways to 
determine which bacteria might be likely candidates in Crohn's disease is to identify 
microorganisms that are present in diseased tissues but not in controls. Temporality refers 
to the necessity that exposure precedes the disease ( Fletcher et al. I 996 ). According to 
Rothman (1982), causation is not possible without the cause occurring before the effect. 
The results presented herein will review application of six epidemiologic causal criteria 
outlined by Hill, to the relationship between other enteric microbes and Crohn's disease. 
"Specificity of association·· refers to the fact that an exposure leads to a single or 
characteristic effect. It is easier to support causation when associations are specific, but 
this may not always be the case, since many exposures cause multiple diseases (Susser, 
1988). According to Susser (1988), specificity adds plausibility to the causal claim, but if 
absent does not detract from it. 
In the present study, it was observed that the criterion of ··specificity of effect" was 
not fulfilled by any of the considered microbes, while the criterion of "dose-response" was 
not applicable to all the organisms based on available evidence. Thus the remaining 
discussion will be based on the other four established epidemiological criteria by Hill 
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(1965). Table 2.1 shows a comparison of the considered microbes in relation to fulfilling 
the six established epidemiological criteria by Hill ( I 965 ), while Table 2.2 shows the 
number and percentage of experimental evidence used to determine whether or not the 
various microbes has fulfilled any of the six established epidemiological criteria. 
Table 2.1: Comparison of the various microbes in relation to fulfilling the six established 
epidemiological criteria. 
MICROBES Strength Biological Consistency 
of plausibility of effect 
associa-
tion 
I NORMAL -.J v -.J 
INTESTINAL 
FLORA 
II PATHOGENS 
I MAP -v -.J -.J 
2 AIEC -v -.J -.J 
3 Listeria absent -.J -.J 
monocytogenes 
4 Yersinia species -.J -.J -.J 
5 Herpes viruses -v Disputed -v 
(EBY, CMV 
and HHV6) 
6 Measles virus absent Disputed -.J 
7 Norovirus unknown -.J -.J 
Key: 
-.J = experiment conducted and criteria fullfilled; 
Disputed= experiment conducted but contradicting results; 
Absent= experiment conducted but criteria was not fulfilled; 
Unknown = no experiment conducted. 
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Tempor Specificity Dose-
a-lily of response 
associatio relation-
n ship 
unknown absent Not 
applicable 
-.J absent Not 
applicable 
Absent absent Not 
applicable 
unknown absent Not 
applicable 
unknown absent Not 
applicable 
unknown absent Not 
applicable 
unknown absent Not 
applicable 
-.J unknown Not 
applicable 
, 
A 
Table 2.2: Number and percentage of experimental evidence used to determine whether or 
not the various microbes has fulfilled any of the six established epidemiological criteria. 
MICROBES Strength Biological Consistency Tempura- Specificity Dose-
of plausibility of effect lily of response 
associat- association relation-
ion ship 
I NORMAL I I 6 unknown absent Not 
INTESTINAL (5.5%) (4.2%) (14.3%) applicable 
FLORA 
II PATHOGENS 
I MAP 4 7 9 3 absent Not 
(25.0%) (29.2'%) (23.6%) (75.0%) applicable 
2 AIEC 5 3 5 Absent absent Not 
(31.3%) (12.5%) (13.2%) applicable 
3 Listeria absent 2 2 unknown absent Not 
monocytogens (8.3%) (5.3'Yo) applicable 
4 Yersinia 6 5 I unknown absent Not 
species (37.5%) (20.8%) (2.6%) applicable 
5 Herpes viruses I Disputed 13 unknown absent Not 
(EBV,CMV (6.3%) (34.2%) applicable 
and HHV6) 
6 Measles virus absent Disputed 6 unknown absent Not 
( 15.8%) applicable 
7 Norovirus unknown 6 2 I unknown Not 
(25.0%) (5.3%) (25.0%) aoolicable 
Total 16 24 38 4 
(100%) (100%) ( 100%) ( 100%) 
Key: 
Disputed= experiment conducted but contradicting results: 
Absent= experiment conducted but criteria was not fulfilled: 
Unknown = no experiment conducted. 
Normal intestinal flora 
The human intestine normally harbors a large and dynamic bacterial community. In 
most cases the bacteria are harmless and even protective. However, there is a substantial 
body of evidence implicating the resident flora in the pathogenesis of chronic intestinal 
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inflammation. The three established epidemiological criteria fulfilled by normal intestinal 
flora include: consistency of effect, biological plausibility and strength of association, 
Consistency of e_ffect: Multiple investigators have reported a possible link between 
commensal bacteria and Crohn · s disease ( Fiocchi. 1998 ). It is reported that not only the 
abundance but also the composition of the mucosa-associated flora is abnormal in Crohn · s 
disease. Data from literature suggest that the mucosa! flora in Crohn's disease patients is 
abnormal even before the onset of inflammation (Bourlioux ct al. 2003 ). Studies have 
shown that some E. coli strains can be damaging, and some have been identified in Crohn's 
disease that bind excessively to the intestinal walls and can penetrate the lining. Studies 
have demonstrated the importance of the enteric microflora in the development of 
inflammatory bowel disease (IBO) in rodents with engineered susceptibility (Elson ct al., 
2005; Kim et al., 2005). Research has also demonstrated an abnormal mucosa-associated 
flora, considered to interact most closely with the innate immune system, in people with 
IBO (Kleessen et al., 2002; Swidsinski et al., 2005 ). 
Biological plausibility: Many investigators have shown that the interaction of 
commensal bacteria with the intestinal immune system is an important factor in the 
development of Crohn's disease. It is reported that the study of isolated commensal 
bacteria's effects on the mucosa) immune response is essential for an improved 
understanding of pathophysiological mechanisms in Crohn's disease (Llopis and 
colleagues, 2008). Llopis and co-workers investigated the immune responses to signals 
from the commensal Escherichia coli A TCC 35345 and the probiotic Lactohacillus casei 
ON-114 001 in Crohn's disease mucosa. Their results indicated that live L. casei 
significantly decreased secretion of TNF-alpha. IFN-gamma, IL-2. IL-6, IL-8, and CXCLI 
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by CD mucosa, but the effect was not reproduced by L. casei DNA. In addition, live L. 
casei downregulated expression of IL-8, IL-6. and CXCLI and did not modify expression 
ofIL-23pl9, IL-12p35, and IL-17F. In contrast it was observed that E.coli significantly 
upregulated expression of all these cytokines. These researchers concluded, based on 
combination experiments, that Live L. casei can prevent and counteract the 
proinflammatory effects of £. coli on Crohn's disease inflamed mucosa by specific 
downregulation of key proinflammatory mediators. In the present study we report that the 
criteria of biological plausibility have been accomplished by All:C and Crohn 's disease 
based on existing data. 
Strength of association: Available data have shown that more intestinal flora were 
detected on the intestinal mucosa) surface of Crohn's disease patients than on those of 
controls. Kleessen et al. (2002) investigated IBO tissues for different bacterial population 
groups harbouring the mucosa) surface and/or invading the mucosa. Their results showed 
that more bacteria were detected on the mucosa) surface of IBO patients than on those of 
non-IBO controls. In addition, it was discovered that colonic ulcerative colitis specimens 
were colonized by a variety of organisms, such as bacteria belonging to the gamma 
subdivision of Proteobacteria, the Enterobacteriaceae, the Bacteroides/Prevotella cluster, 
the Clostridium histolyticum/Clostridium lituseburense group. the Clostridium 
coccoides/Eubacterium rectale group, high G + C Gram-positive bacteria, or sulphate-
reducing bacteria, while Crohn's disease samples harboured mainly bacteria belonging to 
the former three groups. They concluded that pathogenic events in Crohn's disease and 
ulcerative colitis may be associated with different alterations in the mucosa! flora of the 
ileum and colon (Kleessen et al. 2002). Lodes and colleagues (2004) conducted a study to 
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identify commensal bacterial proteins that could contribute to the pathogenesis of IBO, 
using serological expression cloning. These investigators found increased concentrations 
of circulating lgG antibodies to flagellins in patients with Crohn 's disease but not 
ulcerative colitis or controls. All these findings suggest that the criteria of ··strength of 
association" have been fulfilled by normal intestinal flora. 
Dose reponse relationship: Numerous studies have reported on the use of 
antibiotics and probiotics to manipulate intestinal bacterial flora for therapeutic purposes in 
Crohn's disease patient (Gionchetti ct al. 2006; Balfour, 2007). However, since no titration 
of dosages of the antibiotics has yet been performed, we report that the established dosc-
reponse relationship criteria have not been fulfilled by normal intestinal flora. 
Intestinal pathogens 
Numerous intestinal pathogens have been considered in the search for microbes 
associated with occurrence or exacerbation of Crohn's disease, including bacteria (MAP, 
AIEC, Listeria monocytogenes, Yersinia enterocolitica) and viruses (herpesviruses, 
measles virus, noroviruses ). 
Mycobacterium avium subspecies paratuherculosis 
An important suspect for Crohn's disease 1s Mycohacterium avium subspecies 
paratuberculosis (MAP), described as an obligate intracellular bacteria that is known to 
cause paratuberculois (Johncs disease) in ruminant animals. In a previous study, we 
(Uzoigwe et al. 2007) reported that the MAP Crohn's disease phenomenon has fulfilled at 
least four (strength of association, consistency of effect, temporality and biological 
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plausibility) of the six epidemiologic causal criteria outlined by Hill. These four 
epidemiological criteria fulfilled by MAP arc briefly discussed below. 
Consistency of effect: Several investigators (Mishina et al. 1996; Chamberlin et al. 
2001; Hermon-Taylor et al. 2000; Hultcn ct al. 2001; McFadden et al. 1987; Sechi et al. 
2005; Karp et al. 2007) have reported the isolation of MAP from patients with Crohn's 
disease. Karp and coworkers (2007) evaluated new knowledge and data involving MAP in 
Crohn's disease by examining relevant publications in the literature. Over 145 new clinical 
and laboratory studies supported an association between MAP and Crohn"s disease. There 
have been several reports of a significantly higher frequency of MAP in intestinal tissue 
obtained from patients with Crohn ·s disease. by use of several different methods of 
analysis (Karp et al. 2007, Autschbach et al. 2005 ). Several different methods of analysis 
have included similar findings. Autschbach et al. (2005) reported that IS900 PCR detection 
rate was significantly higher in Crohn's dsease tissue samples (52%) than in ulcerative 
colitis (2%) or nIBD (5%) specimens (p<0.0001 ). Sechi ct al. (2001) reported on the 
presence of cell wall-deficient Mycohaclerium avium subsp. pararuhercu/osis in 35 of 48 
paraffin-embedded tissue specimens from 33 patients with Crohn's disease, using the 
method of in situ hybridization with IS900 as a probe. Na'icr and co-workers (2004) 
reported the culturing of Mycohaclerium avium subspecies pararuherculosis from the 
peripheral blood in 50% of patients with active Crohn"s disease. 
Biological plausibilily: The mechanism of tissue damage by MAP in Crohn's 
disease has been reported. It is reported that MAP does not produce any toxins or posions. 
The damage to the intestine is attributed to the inflammatory process (Danze et al. 1996; 
Hodgson, 1996; Sartor, 1995 ). It has been shown that MAP produces disease in humans by 
51 
over-stimulating the immune system (Schwartz et al. 2000; Danze et al. 1996). 
Investigators reported that the immune system recognizes the "foreign" proteins of the 
bacteria, even inside a living cell and mounts a furious attack that results in massive 
inflammation, ulcers, diarrhea and weight loss (Schwartz ct al. 2000: Danzc ct al. 1996; 
Hodgson, 1996; Sartor, 1995 ). 
Strength of association: Numerous investigators (Mishina ct al. 1996; Scchi ct al. 
2005; Chamberlin et al. 200 I; Chiodini et al. 1984) reported the identification and/or 
isolation of MAP from a significantly higher proportion of Crohn's disease tissues than 
from controls. Sechi et al. (2005) demonstrated that twenty five patients (83.3%) with 
Crohn's disease and 3 control patients ( 10.3%) were IS900 PCR positive (p = 0.000001; 
Odds ratio 43.3). These researchers showed that Mycobacterium avium subspecies 
paratuberculosis grew in cultures from 19 Crohn's patients (63.3%) and from 3 control 
patients (10.3%) (p = 0.00001; Odds ratio 14.9) (Sechi ct al. 2005). 
Temporality: Studies using animal models have shown that exposure to MAP 
preceded the development ofCrohn's disease. Van Kruiningen ct al. (1986), reported that a 
goat infected with the MAP organism taken from a human patient with Crohn's disease, 
showed progression to Johne's Disease. In another study, it was demonstrated that twenty-
four day-old specific pathogen-free Leghorn-Cochin chicks could be infected by multiple 
exposure routes using the same MAP strain ("Linda") (Van Kruiningen et al. 1991 ). 
Mutwiri and coworkers (2001) demonstrated that infection of six-week-old beige/scid mice 
with MAP, triggers significant intestinal pathophysiologic changes consistent with chronic 
inflammation. Vaughan and colleagues (2005) reported the development of a 
paratuberculosis infection model in a breeding group of adult and juvenile New Zealand 
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white laboratory rabbits following oral administration of three doses of the MAP strain. 
CLIJ623, on three occasions. These researchers monitored the disease progression in the 
rabbits for more than 2 years, using culture. post-mortem tissue bacteriological culture and 
histopathology. Their results showed that of the 4 adult and 16 juvenile orally dosed 
rabbits, MAP organisms were recovered bacteriologically from two and three animals, 
respectively, using the BACTECTM radiometric culture system (Vaughan and colleagues. 
2005) 
Specificity of association. We reported earlier that MAP docs not demonstrate 
specificity of association in regard to Crohn's disease (Uzoigwc ct al. 2007), due to failure 
to detect MAP in some studies (Riggio et al. 1997; Chiba et al. 1998a; Kanazawa et al. 
1999). Sibartie et al. (20 IO) conducted a study to examine the influence of MAP on T-cell 
proliferation and cytokine responses in patients with inflammatory bowel disease, and their 
results showed an increased proliferation of T cells and an altered cytokine response, 
which suggested that prior exposure to MAP and engagement of the immune system is 
seen in patients with Crohn's disease. They concluded that their results docs not imply 
causation but does support further examination of MAP as an environmental modifying 
factor in Crohn's disease. By extension, other enteric pathogens implicated in Crohn ·s 
disease could not fulfill the criteria of ··specificity of association··, since the specific 
agent(s) that may cause ofCrohn's disease have not yet been confirmed. 
Dose-re,1,ponse relationship. It is reported that the intestinal mucosa) layer from 
patients with inflammatory bowel disease had high numbers of MAP bacteria compared 
with people without Crohn · s disease. but no correlation was found between the numbers of 
bacteria present and either the degree of inflammation or the use of anti-inflammatory 
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agents or sulfasalazine compounds (Schwartz et al. 2000). According to Greenstein et al. 
(2007), methotrexate and 6-mercaptopurine inhibit MAP growth in vitro. I lowever, the 
dosages of methotrexate and 6-mercaptopurine in clinical use have not been titrated 
according to standard antibiotic conventions. These studies suggest that a demonstration of 
dose response criterion may not be applicable to the relationship between enteric microbial 
agents and Crohn's disease. 
Adhesive-invasive Escherichia coli 
Some E. coli strains, particularly the adherent-invasive E coli (AIEC) pathovar, 
have been increasingly implicated in the etiology and pathogenesis of Crohn's disease. 
Based on available evidence, the three established criteria fulfilled by AIEC include: 
consistency of effect, biological plausibility and strength of association. 
Consistency of effect: Numerous investigators (Darfcuille-Michaud, 2002: Bringer 
et al. 2006; Rolhion et al. 2007) have demonstrated an association between Crohn' s disease 
and a strain of E. coli known as adherent-invasive E. coli (AIEC) strain LF82. Bringer et 
al. (2006) reported that the Crohn's disease-associated adherent-invasive Escherichia coli 
strain LF82 replicates in mature phagolysosomes within 1774 macrophages. Rolhion et al. 
(2007) showed that OmpC and the 0E regulatory pathway arc involved in adhesion and 
invasion of the Crohn's disease-associated Escherichia coli strain LF82. Meconi et al. 
(2007) demonstrated that adherent-invasive Escherichia coli (AIEC) LF82 isolated from a 
Crohn's disease patient induced granulomas in vitro. Martinez-Medina et al. (2009) 
conducted a study about the ecological parameters of AIEC, and their results reinforced the 
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implication of AIEC in Crohn·s disease. These findings indicate that AIEC Crohn's 
disease phenomenon satisfy the criteria of "consistency of effect". 
Biological plausibility: It is reported that AIEC LF82 virulent bacteria. but not 
nonpathogenic E. coli K-12. were able to persist in the gut of (TABAC 10 transgenic mice 
and to induce severe colitis with reduced survival rate. marked weight loss, increased rectal 
bleeding, presence of erosive lesions. mucosa! inflammation. and increased 
proinflammatory cytokine expression (Carvalho et al. 2009). A study conducted by 
Darfeuille-Michaud (2002), showed some of the mechanisms underlying tissue damage by 
AIEC in Crohn's disease. Darfeuille-Michaud (2002). reported that a pathovar of E. coli, 
designated adherent-invasive Escherichia coli (AIEC) colonize the intestinal mucosa by 
adhering to intestinal epithelial cells, and arc also recognized as true invasive pathogens 
with the ability to invade intestinal epithelial cells via a macropinocytosis-like process, and 
to survive and replicate intracellularly after lysis of the endocytic vacuole. These 
researchers additionally showed that within macrophages. AIEC strains survive and 
replicate extensively without inducing host cell death and induce the release of high 
amounts of TNFalpha cytokine. They further reported that all these virulence properties 
possessed by AIEC designate it as a possible pathogen with the potential to induce 
persistent intestinal inflammation in Crohn' s disease. by crossing and breaching the 
intestinal barrier, moving to deep tissues. and continuously activating macrophages. 
Rolhion et al. (2007) reported that OmpC and the crE regulatory pathway are involved in 
adhesion and invasion of the Crohn's disease-associated Escherichia coli strain LF82. 
Strength of association: Several studies have shown that AIEC could be isolated 
from intestinal tissue of Crohn · s disease patients but not from control tissue. Kotlowski ct 
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al. (2007) reported a higher prevalence of£ coli from the 82+D phylogenetic group in 
tissues of patients with ulcerative colitis and Crohn · s disease compared to controls. These 
researchers collected a total of 84 biopsies from 15 controls. 13 patients with Crohn · s 
disease and 19 patients with ulcerative colitis. The DNA extracted from each biopsy 
sample was subjected to RISA analysis. and their results identified bands (-450 bp) that 
were consistently present in approximately 70% of patients but in <30% of controls 
(Kotlowski et al. 2007). Several studies have revealed a high prevalence of invasive strains 
associated with the ilea) mucosa of patients with Crohn's disease compared to that for 
controls, supporting a putative role of E. coli invasiveness in the pathogenesis of Crohn's 
disease (Boudeau et al. 2000; Masseret et al. 200 I). A study conducted by Darfeuille-
Michaud et al. (2004) showed a high prevalence of adherent-invasive Escherichia coli 
associated with ileal mucosa in Crohn's disease compared to controls. These researchers 
reported isolation of the AIEC reference strain LF82 from ilea) specimens of 21. 7% of 
Crohn's disease patients compared to 6.2% of controls ( Darfeuille-Michaud ct al. 2004 ). 
Another study (Martin et al. 2004) demonstrated that mucosa-associated E. coli. which 
accounted for 53% of isolates, were more common in Crohn's disease (43%) than in 
noninflamed controls (17%), and that intramucosal E. coli were found in 29% of Crohn's 
disease patients compared to 9% of controls. Their study supported a role for mucosally 
adherent bacteria in the pathogenesis of Crohn's disease and colon cancer (Martin et al. 
2004 ). In this study, based on exisiting data, we report that the criteria of strength of 
association have been fulfilled for AIEC and Crohn's disease. 
Temporality: Studies have shown that the presence of AIEC is increased in Crohn · s 
disease patients. It is also reported that in patients with inflammatory bowel diease, AIEC 
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can adhere to intestinal epithelial cells and induce the secretion of IL-8. but there is no 
evidence that these E. coli strains are invasive (Rolhion and Darfcuille-Michaud. 2007). 
According to Rolhion and Darfeuille-Michaud (2007). the absence of invasiveness of 
AIEC strains, could imply a possibility of not inducing the formation of granulomas or any 
other lesion, when applied to pathogen free animal models. Based on this finding, we 
report that the temporal sequence criteria have not been fulfilled for the association 
between Crohn's disease and AlEC. 
Specificity of effect: While some studies have reported the presence of AIEC m 
Crohn's disease patient's intestinal mucosa. some other studies have failed to detect this E. 
coli strain in Crohn's disease tissue. Walmsley et al. ( 1998) reported the absence of 
Escherichia coli, Listeria monocyloKenes, and Klehsiella pneumoniae antigens within 
inflammatory bowel disease tissues. Due to the inability to detect AIEC in some studies, 
this study reports that the criteria of specificity of effect have not been fulfilled. 
Dose-response relationship. Several antibiotics with the ability to penetrate 
macrophages have been used as a target for the AIEC strain. which replicate within 
macrophages. Although investigators reported that azithromycin. ciprofloxacin, rifampicin, 
sulfamethoxazole, tetracycline and trimethoprim were all effective against E. coli within 
macrophages (Subramanian et al. 2008 ), there arc no data indicating that the dosages of 
these antibiotics have been titrated according to standard antibiotic conventions. Thus, in 
the present study. we conclude that demonstration of dose response criterion may not be 
applicable to the relationship between AIEC and Crohn·s disease. 
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Listeria monocytogenes 
Listeria monocytogenes. a Gram-positive, rod-shaped, facultative intracellular 
organism, has been implicated in the etiopathogenesis of Crohn's disease, and has been 
shown to fulfill three established epidemiological criteria, including consistency of effect. 
biological plausibility, and strength of association. 
Consistency of effect: The bacteria Listeria mon<nywgenes have been proposed as 
candidate causative agents ofCrohns disease (Liu ct al. 1995). Liu ct al. (1995) reported 
that Listeria spp., E. coli, and streptococci, but not measles virus, play a role in the 
pathogenesis of Crohn's disease. Hugot et al. (2003) reported that Crohn's disease is the 
result of an excessive response to pathogenic psychrotrophic bacteria in some genetically 
predisposed people. The cold chain hypothesis suggests that Crohn's disease results from 
an increased and chronic exposure to psychrotrophic bacteria (microbes which are able to 
survive at low temperatures). such as Yersinia .\pp and Listeria .,pp. ( Hugot ct al. 2003 ). 
Biological plausibility: Investigators reported that the consumption of refrigerated 
food containing low levels of psychotropic, pathogenic bacteria causes an over-active 
immune response, resulting in Crohns Disease (Ilugot ct al. 2003 ). Nakanc ct al. (1988) 
reported that a lower level of TNF-alpha is produced endogenously in mice that received L. 
monocytogenes infection and that it plays an essential role in the host def cnse against L 
monocytogenes infection. Thus. the criteria of biological plausibility have been 
accomplished by Yersinia .,pecies. 
Strength of association: Investigators have shown that Listeria monocytogenes 
have not been isolated from the lesions of Crohn's disease patients at higher rates than in 
controls (Chen et al. 2000). These researchers reported that L. monocytogenes DNA was 
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detected in 13.0% patients with CD. 17.9% patients with UC and 25.6% non-IBD control 
patients or in 29 of 274 ( 10.6%) endoscopic biopsies. They concluded that Listeria 
monocytogenes DNA was detected in the intestine of both patients with IBD and in non-
IBO control patients, which probably reflect the widespread presence of this organism in 
the environment, and does not support a direct role fr)r L mono9·togenes in the 
pathogenesis of IBO. Thus, the criterion of "strcnght of association" is believed not to be 
fulfilled by Listeria monocytogenes. 
Temporality: There arc no data available which show that exposure to L. 
monocytogenes preceded the development of Crohn's disease. Hence, fulfillment of the 
temporality criteria for L. monocytogenes is reported as unknown. 
Specificity of effect: While previous studies have demonstrated the presence of 
Listeria antigens in intestinal tissue of Crohn ·s disease patients (Liu et al. I 995 ), some 
other studies (Chiba and coworkers. I 998: Walmsley. 1998) reported that their data does 
not support the etiologic significance of L. monoqtogenes in Crohn's disease. Thus the 
criterion of specificity of effect is regarded as not accomplished by Listeria 
monocytogenes. 
Dose-re5ponse relationship: Similar to other bacterial agents implicated in Crohn's 
disease, the criteria of dose-response relationship could not be applied to L. 
monocytogenes, since there arc no experimental data on titration of drugs used for 
treatment of Crohn' s disease. 
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Y ersinia species 
The genus Yersinia consist of Gram-negative coccobacillus-shaped group of 
bacteria, that includes three species Y. pesti.,. Y. pseudotuherculosis and r. enterornlitica 
which are pathogenic for humans and rodents. J'ersinia pestis is the etiologic agent of 
plague, while Y pseudotuberculosis and Y. enterornlitica are intestinal pathogens that 
cause commonly self limited enteritis called yersiniosis and mesenteric adenolymphitis in 
humans. These enteropathogenic J'ersinia strains. Y. pseudotuherculosis and Y. 
enterocolitica, have also been suggested to play a causal role in Crohn·s disease. In the 
present study, Yersinia !>pecies have been shown to fulfill three established 
epidemiological criteria, including consistency of effect. biological plausibility and 
strength of association. 
Consistency of effect: Many authors have independently found Yersinia species in 
Crohn's disease lesions, and have reported an association between Yersinia species and 
Crohn's disease (Kallinowski et al. 1998; Lamps et al. 2003 ). Several lines of evidence 
support a link between enteropathogenic Yersinia species and Crohn's disease. including: 
(i) Y enterocolitica and Y pseudotuherculosis have been found in Crohn 's disease lesions 
(Kallinowski et al. 1998; Lamps et al. 2003; Swidsinski et al. 2002); (ii) investigators have 
shown that Crohn's disease may occur after a Yersiniosis (Sacbo ct al. 2005 ); (iii) the 
clinical manifestations of Crohn' s disease and Y ersiniosis are both characterized by ileitis 
or ileocolitis with formations of granulomas and in some cases by reactive arthritis; and 
(iv) studies have shown an increase in responsivity of mononuclear cells isolated from 
mesenteric lymph nodes of Crohn · s disease patients to Y. enterocolitica when compared to 
other bacterial agents such as £. coli. Salmonella URona. Candida alhicans or Chlamydia 
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trachomatis (Ibbotson et al. 1992 ). The presence of granulomata is a characteristic of 
infections where the causative organisms are capable of exisiting intracellularly and is a 
feature found in mycobacterial and yersinial diseases. According to the cold chain 
hypothesis, Crohn's disease is assumed to result from chronic exposure to bacteria able to 
grow at low temperature called psychrotrophic bacteria, which includes }'ersinia .,pp and 
Listeria spp. (Hugot et al. 2003 ). In this study. the criterion of consistency of effect is 
considered fulfilled, since the association between the cntcropathogcnic Yersinia strains 
and Crohn's disease has been demonstrated in multiple studies. 
Biological plausibility: It is reported that mice invalidated for CARD 15/NOD2 are 
characterized by an abnormal response after oral infection by Yersinia pseudotuherculosis 
(Meinzer et al. 2008). Studies have shown that entcropathogcnic J'ersinia strains display a 
tropism to lymphoid tissue (Brubaker, 1991 ). Many researchers (Autenricth and Firsching, 
1996; Clark et al. 1998) demonstrated that the entcropathogenic Yersinia species bind to 
and invade M cells within the follicle-associated epithelium overlying the lymphoid 
follicles of the Peyer's patches. After their entry into Pcycr's patches. the bacteria induce 
the host immune response which is characterized by an inflammation with infiltration of 
immune cells, particularly neutrophils and macrophages (Handley ct al. 2004 ). Since there 
are data describing the mechanism of tissue damage by Yersinia .,pecies. the criteria of 
biological plausibility is said to be accomplished in this study. 
Strength of association: Lamps and colleagues (2003) reported that Yersinia DNA 
is detected in bowel and mesenteric lymph nodes from patients with Crohn · s disease at 
higher rates than in controls. This finding indicates that this criterion has been fulfilled by 
Y ersinia species. 
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Temporality: It is known that the Nucleotide oligomerisation domain 2 (NOD2) is a 
component of the innate immunity involved in the homeostasis of Peyer· s patches in mice. 
and NOD2 mutations have been associated with Crohn's Disease (Hugot et al. 2001; Ogura 
et al. 2001). Meinzer et al. (2008) investigated the role of Nod2 during Y. 
pseudotuberculosis infection. Their results showed that mice invalidated for CARD 
15/NOD2 are characterized by an abnormal response after oral infection by Yersinia 
pseudotuberculosis (Meinzer et al. 2008). These researchers concluded that Nod2 
contributes to the susceptibility to r pseudotuherculosis in mice. A study conducted by 
Scandivanian researchers (Saebo et al. 2005) showed that at the population level, Crohn's 
disease is more frequent in the years following a recorded Yersinia infection. However, in 
contrast to the bacteria MAP, there are no specific studies indicating that exposure to 
Yersinia species preceded the development of Crohn's disease using animal models. Thus 
in this study, the fulfillment of the criterion of temporality is reported a'i unknown. 
Specificity of effect: Some authors have reported the detection of entcropathogenic 
Yersinia species in Crohn·s disease patient is intestinal tissues (Meinzer et al. 2008), and 
that individuals with Yersinia infection arc more likely to progress to Crohn's disease 
(Saebo et al. 2005). However, some other investigators ( Persson et al. 1976) reported that 
acute yersiniosis never progesses to Crohn · s disease. Due to contradictory results, the 
criterion of specificity of effect is reported as not fulfilled by Yersinia species. 
Dose-response relationship: This criterion is not applicable to Ycrsinia species, 
since there are no data on titration of dosages of drugs used for treatment of Crohn·s 
disease. 
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Herpes viruses 
Research suggests that herpes viruses might play a signifil:ant role in the 
pathogenesis of Crohn's disease. The two established epidemiological criteria fulfilled by 
herpesviruses include: consistency of effect and strength of association. 
Consistency of effect: Many authors reported the presence of herpes virus DNA in 
intestinal tissue of Crohn's disease patient (\Vakefiled ct al. 1992; Ruther ct al. 1998). A 
study conducted by Wakefield and coworkers ( 1992) have shown a high prevalence of 
herpesviruses (such as cytomegalovirus. human herpes virus 6. and Epstein Barr virus) 
infection in Crohn' s disease patients. Ruther ct al. ( 1998 ), used in-situ hybridization to 
investigate intestinal mucosa for viral agents such as HSY I + II- and Epstein-Barr virus 
DNA, and found these DNA in the cell nuclei in the surface and glandular cpithclia of the 
affected mucosa of the small intestine and the colon. Their findings indicated that viruses 
may exacerbate these inflammatory bowel diseases (Ruther ct al. 1998). Studies have 
shown that cytomegalovirus infection (CMY) infection is related to inflammatory bowel 
disease, either as a precipitating factor or as a coincidental infection (Cottone et al. 2001; 
Berk et al. 1985; Orvar et al. 1993; Fanner ct al. 1973; Bcmades, 1980; Kaufman ct al. 
1999; Rachima et al. 1998 ). Cottone ct al. (2001) reported that cytomcgalovirus infection 
is a cause of severe refractory ulcerative and Crohn's colitis. The presence of Epstein Barr 
virus (EBY) in intestinal tissues from Crohn · s disease patients has been demonstrated by 
many investigators using PCR (Wakefield et al. 1992). immunohistochcmistry or in situ 
hybridization (Spieker and Herbst. 2000: Yanai et al. 1999 ). Yanai ct al. ( 1999) 
investigated the possible pathological role of EBY in inflammatory bowel disease (IBO), 
by testing for the presence of EBY in the colon in IBD patients. Their results showed a 
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limited presence of EBY-infected cells in the diseased areas of IBD colonic specimens. 
indicating that EBY infection may be related to such diseases. Since the association 
between Crohn's disease and herpesvirus infections has been well described in multiple 
studies, the criteria of consistency of effect is reported as fulfilled by herpesviruses. 
Biological plausihility: Studies have shown Interleukin 12 ( I L-12 ). is a potent 
proinflamrnatory heterodimeric. macrophage-derived cytokine that plays an essential role 
in rodent models of inflammatory bowel disease (IBD). and may also contribute to the 
pathogenesis of human disease ( Monteleone et al. 1997 ). It is reported that EBJ3 encodes a 
protein that shares 27% amino acid sequence identity with the p40 component of IL-12. 
and is considered a molecule belonging to the interleukin (IL)-12 family (Devergne et al. 
1996). In view of the homologies between EB 13 and I L-2. it was reasonable to consider 
EBB in the pathogenesis of inflammatory bowel disease. Gehlert ct al. ( 2004) examined 
EB 13 expression in mouse intestine. and reported an increased expression level of the 
EBB, in ulcerative colitis as compared to Crohn's disease. In contrast to the above studies, 
Christ et al. (1998) showed that EBI3 expression is observed at low levels in normal 
human intestine and Crohn·s disease and is significantly up-regulated within macrophage-
like cells in the context of active ulcerative colitis but not active Crohn ·s disease. Based 
these contradictory findings. we report in this study that the criteria of biological 
plausibility is under dispute. 
Strength of association: Researchers ( Wakefield ct al. 1992) examined the 
prevalence of herpesvirus DNA in inflammatory bowel disease tissue and their results 
showed that there was a high prevalence of CMY (81 %). HHY6 (76%). and EBY (76%) 
DNA in ulcerative colitis tissue compared to Crohn's disease tissues (CMY 66%. HHY6 
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45%, EBV 55%). It was also shown that control tissue had a relatively low frequency of 
CMV (29%) and EBV ( 19%) DNA but a prevalence of HHV6 DNA similar to that of 
ulcerative colitis (86%). Since herpesvirus was isolated from a higher proportion of 
Crohn's disease tissues than from controls, we report that criterion of strength of 
association has been fulfilled by Crohn's disease. 
Tempora/ity: There are no available data indicating that animal models infected 
with herpesvirus, subsequently developed Crohn 's disease. Thus the fulfillment of the 
criteria of temporality by herpes virus is reported as unknown. 
Specificity of effect: While some studies have reported that identification of 
herpesviruses in Crohn · s disease intestinal tissues ( Wakefield et al. 1992 ), some other 
studies have reported their absence (Sura et al. 2010). Sura et al. (2010) recently found 
equal evidence of HHV-6 in patients and controls by multiple methods, which suggests 
that this virus is ubiquitous and probably not a cause of Crohn's disease. In this study, we 
report that the criteria of specificity of effect have not been accomplished by herpes 
viruses. 
Dose-re!>ponse relationship: Similar to bacterial agents implicated m Crohn's 
disease, the criteria of dose-response relationship is not applicable to viral agents like 
herpesvirus, since there are no experimental data on titration of dosages of antiviral drugs 
used for Crohn's disease patients. 
Measles virus 
Measles virus, both wild-type and vaccine-attenuated, acquired either in utero, or as 
a consequence of postnatal infection has been suggested as a risk factor for Crohn's 
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disease. The only epidemiological criteria fulfilled by measles virus is the consistency of 
effect. The criteria of biological plausibility is said to be disputed. 
Consistency <~l effect: Several investigators reported the detection of measles virus 
particles, protein or RNA in tissues from patients with Crohn·s disease. using direct 
electron microscopy, immunohistochcmistry and in situ hybridization techniques 
(Wakefield et al. 1993; 1997: Miyamoto ct al. 1995: Daszak ct al. 1997: Lewin ct al. 1995: 
Ekbom et al. 1994; Thompson ct al. 1995 ). Since the isolation of measles virus from 
Crohn's disease tissue has been demonstrated in multiple studies. the measles virus-
Crohn's disease phenomenon is reported to satisfy the criteria of "consistency of effect". 
Biological plausibility: The biologically plausible hypothesis linking measles virus 
exposure with the subsequent development of Crohn·s disease is still disputed. One group 
of investigators reported that the measles virus is able to persist within the mesenteric 
endothelium, and its presence induces an inflammatory reaction characteristic of Crohn·s 
disease, which suggests a biological plausibility between measles virus and Crohn's 
disease (Wakefield et al. 1995). In contrast. another group of researchers (Haga et al. 1996) 
reported the absence of measles viral genomic sequence in intestinal tissues from Crohn's 
disease by nested polymerase chain reaction. Additionally, the data relating to the humoral 
immune response against measles virus in patients with Crohn · s disease arc still under 
debate. Lavy et al. (2001) reported that the presence of lgG antibodies to measles virus was 
higher in patients with Crohn's disease than in patients with ulcerative colitis or controls. 
These researchers also demonstrated that exposure to measles in childhood was more 
frequent in Crohn's disease patients than in their controls, the difference being statistically 
significant (p < 0.05) in relation to community controls. These observations supported a 
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role for measles infection in Crohn's disease ( Lavy et al 200 I ). Whereas one group of 
investigators found measles virus specific IgG antibodies in the majority of subjects with 
Crohn's disease (Lavy et al 2001 ). other groups could not detect any immunological 
evidence of persistence of measles virus or any differences compared with control groups 
(Balzola et al. 1997; Touze et al. 1995: Fisher ct al. 1997). Since Crohn"s disease has not 
been linked persistently with measles virus, the biological plausibility for the measles virus 
to cause Crohn's disease, as has been proposed. is considered "disputed". 
Strength of association: Robertson and Sandler (200 I) reported the use of well-
accepted Bradford-Hill criteria to evaluate the possible causal association between measles 
and IBD. Their results indicated that although the association may be biologically 
plausible, the literature lacks consistency. specificity, strength, and dose response. Their 
study does not support an association between measles virus and IBD (Robertson and 
Sandler, 200 I). 
Specificity of effect: Epidemiological results have demonstrated an increased risk of 
Crohn's disease in children with perinatal exposure to the measles virus (Ekbom ct al. 
1994). However, subsequent investigators have failed to detect measles-virus DNA in the 
intestinal mucosa of Crohn's Disease patients (lizuka ct al. I 995; Robertson and Sandler, 
2001). Haslam ct al. (2000) reported that in utcro or perinatal exposure to seasonal 
environmental factors (e.g measles virus). arc unlikely potential aetiological agents in the 
later development of Crohn · s disease. 
Dose-response relationship: Similar to bacterial agents implicated in Crohn's 
disease, the criteria of dose-response relationship is not applicable to measles virus, since 
67 
, 
.. 
there is no experimental data on titration of dosages of antiviral drugs used for Crohn"s 
disease patients. 
Norovirus 
Noroviruses (commonly Norwalk-like viruses or Winter Vomiting Disease) arc part 
of a group of viruses from the family Caliciviridac that arc responsible for the majority of 
nonbacterial gastroenteritis. an inflammation of the stomach and intestinal lining in 
humans, with its most common symptoms of vomiting and diarrhea (Glass ct al. 2009). 
Recent studies have proposed that noroviruscs arc associated with Crohn"s disease. In this 
study, three established epidemiological criteria have been fulfilled by norovirus. including 
consistency of effect, biological plausibility. and tcmporality. 
Consistency of effect: The association of novovirus and Crohn"s disease has been 
demonstrated in many studies. suggesting that the criteria of "consistency of effect"' have 
been fulfilled by murine norovirus (MNV). Previously. researchers have found that mice 
with an A TG l 6Ll gene variant developed a condition similar to Crohn's in humans, but 
this mutation wasn't enough to trigger the disease ( Cadwell ct al. 2008 ). A recent study by 
Cadwell et al. (2010) demonstrated that a murinc noroviral (MNV) infection and a Crohn's 
disease susceptibility gene combine to cause inflammatory disease in the mouse gut. 
According to these scientists. mice with the ATG J 6L 1 gene mutation only developed 
Crohn's disease if they also arc infected with MNV norovirus (Cadwell ct al. 2010). To test 
whether the mouse norovirus was involved. these scientists orally inf ectcd the mice. A 
week later, the mutant mice displayed Paneth cell abnormalities. Infected control mice, in 
contrast, did not. Paneth cells weren't directly infected with virus. but their gene expression 
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patterns were altered. These findings show that a combinatinn of the virus plus the gene 
mutation, but neither alone. causes abnom1alities in the intestine ( Cadwell et al. 20 I 0). 
Khan et al. (2009) demonstrated that the norovirus infection may be associated with 
exacerbations of inflammatory bowel disease (IBD). They reported that when norovirus 
accompanies IBO it is more likely to be associated with hematochczia than when the 
infection occurs in the absence of IBD (Khan et al. 2009). 
Biological plausibility: Many authors have shown or proposed the underlying 
mechanisms of tissue damage by infection with noroviruses in Crohn's disease. Several 
investigators reported that murine norovirus (MN V) is immunmodulatory and may alter 
disease phenotypes in mouse models of inflammatory bowel disease (Chase ct al. 2008: 
Cadwell et al. 20 I 0). McCartney et al. (2008) reported that MDAS-/- dendritic cells have 
a defect in cytokine response to murine norovirus-1 (MNY-1 ). Studies have shown or 
proposed that infection with certain viruses and an increase in production of the 
inflammatory molecule type I interferon are causes of Crohn's disease (Todd. 2010). 
Virgin et al. (2009) reported that an intracellular receptor, interferon-induced helicase C 
domain I (IFIH 1) or MDAS, is required to suppress mouse norovirus infection It 1s 
reported that, although the receptor interferon-induced helicase C domain I (IFIH I) 1s 
widely expressed, the mice norovirus preferentially infects dendritic cells and macrophages 
of the immune system (McCartney et al. 2008). The above studies indicate the Crohn's 
disease and norovirus hypothesis is biologically plausible. 
Temporality: Cadwell et al. (2008) infected A TC i l Ml mice with a particular strain 
of murine norovirus, called MNY CR6. After 7 days. inflammation showed up in a type of 
intestinal cell called Paneth cells, and the inflammation was similar to that found in 
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individuals with Crohn"s disease in their intestinal Paneth cells. However. when identical 
ATG l 6Ll mice were raised in the absence of murine norovirus in a .. germ-free .. 
environment, they showed no evidence of Paneth cell abnom1ality. In addition. when these 
researchers tested strain of norovirus. it did not have this effect. and the ATG J 6U mice 
stayed healthy. Thus, it is demonstrated that the criteria of temporality have been 
accomplished by norovirus. 
Strength of association. In contrast to MAP. there arc no experimental results 
which show that norovirus has not been isolated from a significantly higher proportion of 
Crohn's disease tissues than from controls. Thus the criterion of .. strength of a<,sociation .. 
has not been fulfilled by norovirus and. is reported as .. unknown ... 
Spec(ficity of effect: The murine noro\'irus has not consistently been isolated from 
intestinal tissues of patients with Crohn·s disease. Therefore. in the present study. we 
suggest that the criterion of .. specificity of effect"" has not been accomplished by norovirus, 
and is reported as .. unknown ... 
Dose-re.\ponse relationship. Studies have shown that the immunosuppressant 
rapamycin, which induces autophagy in cultured cells, improved symptoms in a patient 
with refractory Crohn's disease (Massey ct al. 2008). However. the dosages of rapamycin 
have not been titrated according to standard antibiotic conventions. Therefore in this study, 
the criterion of dose-response relationship is reported as "not applicable ... 
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CONCLUSION 
A study has been conducted investigating whether any of the coterie microbial 
candidates has met any or some of the criteria set by Rothman and others for causality. The 
candidates examined in this study include: MAP. AIEC. Listeria mon<>L:rt<>gl.'nl.'s. Ycrsinia 
species, Herpes viruses (EBY. CMV and HHV6). measles \'irus and noro\'irus. While 
MAP has previously been reported to fulfill four out of the six epidemiological criteria for 
causation, the present study demonstrates that data exist that shows that coterie microbes 
(e.g Normal intestinal flora. AIEC and frrsinia .,pl.'Cil.'s) and Crohn ·s disease phenomenon 
has fulfilled at least three ( consistency of effect. biological plausibility and strength of 
association) of the six epidcmiologic causal criteria outlined by Hill. Norovirus satisfied 
three (biological plausibility. consistency of effect and tcmporality) of the six 
epidemiologic causal criteria. Listaia monocytogl.'nl.'s fut fit led two ( consistency of eff cct 
and biological plausibility). llerpesviruses also fulfilled two (consistency of effect and 
strength of association). while measles virus has fulfilled at least one (strength of 
association and biological plausibility) of the six epidemiological criteria. In addition, this 
present study suggests that in reference to Rothman·s 'pie" model. the existing data arc not 
enough to describe any of the coterie microbial agents. as "sufficient" causes of Crohn's 
disease. Furthermore, while MAP has been reported as a "necessary" cause in Crohn's 
disease, other enteric pathogens cannot currently be classified as a "necessary'' cause in 
Crohn's disease, due to the presence of conflicting and unconvincing existing data. Ba,ed 
on available data, it is difficult to determine if the causal criteria bar has been applied in a 
similar manner to MAP and Crohn · s disease as compared to other coterie organisms and 
Crohn 's disease. More studies that support or refute the causal relationship between other 
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enteric organisms and Crohn·s disease need to be conducted in order for this determination 
to be made. With increasing concern about the transmission of infectious diseases from 
animal to man, attention has refocused on MAP as a candidate organism implicated in the 
etiology of Crohn's disease. Suffice to say that. currently. there is more epidemiological 
evidence that supports the causal link between MAP and Crohn·s disease compared to any 
other enteric organisms. It is possible that the bar for the causal criteria between MAP and 
Crohn's disease has been raised higher than it has been applied in other currently 
scientifically acceptable causal relationships. I lowcver. additional studies arc required to 
further support the role of other entcric microbial agents in Crohn ·s disease. Additional 
research is warranted to confirm or disprove this hypothesis of a microbe or microbes as 
causes of Crohn's disease. 
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PAPER3 
OCCURRENCE OF MYCOBACTERIUM AV/UM 
SUBSPECIES PARATUBERCULOSIS INFECTION IN 
CATTLE IN NORTH DAKOTA, 1995-2005 
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ABSTRACT 
Background: Mycobacterium m·ium subspecies paratuherculosis (MAP) is a bacterium 
that causes Johne's disease, also known as paratuberculosis in cattle and other animals. 
MAP is found in milk and is suspected of having a link to Crohn·s disease. Objective: The 
objective of this study was to evaluate trends and risk factors lllr .\~rcohacterium avium 
subspecies paratuberculosis (MAP) shedding in cattle in North Dakota. Methods: The North 
Dakota State University Veterinary Diagnostic Laboratory records of fecal culture-positive 
MAP cases diagnosed from 1995 to 2005 v.ere examined. Lpidemiological data on clinical 
history, age, sex, breed. herd size and county of origin v.ere extracted. Additionally. data on 
producers enrolled in North Dakota's Voluntary Johne's Disease Control Program were 
obtained from the North Dakota State Veterinarian's oflice. Data were analyzed using 
Geographic Information Systems Arc Info 9.1 software. Epi Info version 6 and SAS version 
9.2. Results: Of the 53 counties in North Dakota. 42 (79%) reported MAP infection (range I -
86, median 6) in both beef (n=204) and dairy cattle (n 175). Also. there was a correlation 
between distribution of cases by county and distribution of producers participating in the ND 
Johne's Disease Voluntary Control Program: participating counties had more MAP cases 
reported than counties without participants. The number of MAP cases reported increased 
during the study period with seasonal trends. as shedding v.as higher in winter and spring than 
summer and fall. Chi-square and logistic regression analyses indicated that large herds. female. 
beef animals and animals greater than four years of age were more likely to be categorized as 
high shedders of MAP than herds v. ithout these attributes. 
87 
INTRODUCTION 
Johne's disease or paratubcrculosis is chronic. non treatable granulomatous enteritis 
caused by Mycobacterium avium subspecies paratuherculosis ( MAP) that affects both 
domestic and wild ruminants (Daniels ct al. 200] ). In recent years, the incidence of Johnc's 
disease is reportedly increasing in many countries worldwide. including the United States 
(US), with considerable economic losses primarily reported in the dairy herds (Johnson-
Ifearulundu et al. 1999; McKcnna et al. 2006: Nielsen and Ersboll. 2006: Raizman et al. 
2007; Roussel et al. 2005 ). Various studies have documented major economic losses in 
dairy and beef cattle herds resulting from decreased production. weight loss. lower 
slaughter value and premature culling of infected cattle (Judge et al. 2005: McKcnna ct al. 
2006; Olsen et al. 2002; Raizman et al. 2007; Roussel ct al. 2005 ). Major obstacles to 
control of Johne's disease include identifying subciinically infected animals (Daniels et al. 
2003) and the wide host range in domestic and wild animals ( llosm1:r and Lcmcshow. 
2000; Manning and Collins. 2001: Olsen ct al. 2002: Sechi ct al. 2004: Stabel ct al. 2002: 
Uzoigwe et al. 2007). Studies have shown that only one in 20 infected animals show overt 
clinical signs of Johne's disease. thus making early detection and culling difficult (Riemann 
and Abbas, 1983 ). 
The negative economic impact caused by decreased animal productivity and 
welfare is often masked, and may appear insufficient to justify large investments in control 
programs by individual farmers. I ivestock industries or govcmm1:nt ( van Scaik ct al. I 996 ). 
MAP has also become a public health concern (Biel ct al. 2005: llcrmon-Taylor ct al. 
2000; Uzoigwe et al. 2007) with some studies reporting that DNA from MAP has been 
found in up to 69% of patients with Crohn's disease (Taylor ct al. 2000: Uzoigwe ct al. 
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2007). Whether this association is causal or merely coincidental is not yet fully understood. 
While this association remains unproven and contentious. public perceptions of a causal 
link represents one of the most important economic risks to the milk and meat industries 
(Manning, 200 I). 
In the US, one study (CAST. I 996) reported that up to J Y~o of herds were infected 
with MAP, causing an estimated $1.5 billion annual loss to the cattle industry ( Ott ct al. 
1999). Because of the economic importance and public health concerns about MAP. many 
states within the US have instituted Johne's disease certi tication programs to eradicate the 
disease. The USDA-US Voluntary Johne's Disease I krd Status Program ( 1998 ). and later 
USDA-Uniform Program Standards for the Voluntary Bovine Johne's Disease Control 
Programs (2006) (USDA-APHIS. 2006). were established to standanlile control programs 
in the US. The North Dakota Voluntary .lohne's Disease Control Program (V JDCP) is a 
sequel of the initial effort started in 2001 to screen the state cattle herds. Farmers 
participating in the VJDCP routinely submit fecal samples along with a disease history fonn 
to state diagnostic laboratories (SDL) fc.ir diagnosis of MAP (Bulaga and Collins. 2000). The 
compilation and dissemination of information from SDL provides infonnation from which 
technical decisions are made for control programs. This information is useful to monitor the 
effectiveness of the control program. and is the basis for making adjustments to the Voluntary 
Johne's Disease Control Program. In general. examination of laboratory data and relating it to 
epidemiological information from the field is essential for strengthening national disease 
monitoring and surveillance systems (MOSS). Revicv. of laboratory information is helpful for 
explaining changes in the disease seen in the field. The objective of this study was to evaluate 
trends and risk factors of MAP shedding in ~orth Dakota (ND) cattle from 1995 to 2005. using 
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data from the North Dakota State L;ni\l:rsit> Veterinary Diagnostic Lanorattir> (NDSl lVDL) 
in Fargo, ND. 
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MATERIALS AND METHODS 
Study design 
A retrospective case series of veterinar) medical records of fecal culture-positive MAP 
infections in cattle diagnosed at the NDSli-VDI. from 1995 to 2005 \\ere examined. Suspected 
fecal samples were processed as follows: conventional fecal culture on I lerrold's egg yolk 
(HEY) agar slants was performed as previously described ( Whitlock and Rosenberger. 1990). 
with brief modifications. Briefly. one gram of feces was added to 20 ml. of sterile distilled 
water, tubes were shaken for 30 minutes and then alhmed to stand undisturbed ft)r 30 minutes. 
Five mL of supernatant were added to a decontaminant mixture containing 25 mL of 0.9% 
hexadecylpyridinium chloride monohydrate and 30 mL of brain heart infusion broth. and the 
samples were allowed to decontaminate overnight at 98.6°1· (37°C). Sample-, 
were centrifuged at 900 xg for 30 minutes and the supernatant discarded. Pellets were re-
suspended in I mL of antibiotic brew containing 50% Bill broth with I 00 ug/rnl. vancomycin. 
I 00 pg/mL nalidixic acid and 50 ug/rnl. arnphotericin B. Tubes were vortexed and incubated 
overnight at 98.6°F. HEY slopes were inoculated with 0.25 rnL of the suspension. Each sample 
was cultivated in duplicate on HEY with mycobactin .I and one tube without mycobactin as the 
culture medium. Tubes were incubated at 98.6°1-' and observed at two-week intervals for 16 
weeks. Isolation of a slowgrow ing. acid-fast organism with colonial morphology typical of 
MAP on HEY with mycobactin. but not on I IEY without rnycobactin. was considered a 
positive culture. Animals were classified as high or low shedders if MAP colonies from 
cultured feces took less or more than two weeks. respectively. 
Epidemiological data on clinical histo~. age. sex. breed. shedder status. herd size. 
season and county of origin of each case \\ere extracted. Additionally. data on producers 
enrolled in V .JDCP were obtained from the '.\orth Dakota State Veterinarian's office. 
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Data analyses 
Information presented in the individual animal data did not have complete entries. 
Only those with 65% or more of complete entries or those with variables of interest were used 
in the analysis. Descriptive statistics of cattle \\ ith MAP infection were summari,,ed using 
SASb and Epi Info version 6. The Ceographic Information System ((ilS) soft,\areL was used to 
display the spatial distribution of bo\ine Johne's disease cases repurted in the state by county. 
and the distribution of producers enrolled in VJDCP by cuunty. 
In the statistical analysis. the MAP shedding status of infected cattle was used as the 
outcome variable. The VOL laboratory protocol classifies an animal as a high or low fecal 
shedder based on whether MAP colonies took less or more than two weeks. respectively. to 
appear. Seasons were classified as winter ( December to February). spring ( March to May). 
summer (June to August) and fall ( September to November). Age and herd size were 
dichotomized using their medians as the cut-off (above as high and below as low). Submission 
patterns were reviewed according to months. seasons. years and their geugraphical origin. 
The cumulative incidence (Cul) was calculated from ( "u/ 1-e 1• where e is the natural 
logarithm, and I is incidence rate (/R). IR was calculated from the number of new positive 
cases diagnosed during each year divided by population at risk at the start of the year. The 
population at risk was calculated from simple moving averages of beef and dairy cattle census 
of 1992, 1997, 2002 and projections made for 2005. 
All listed independent variables of biological relevance to epidemiology of MAP were 
individually assessed by univariate logistic regression analysis (Hosmer and Lemeshow. 2000). 
The variables assessed were age. sex. county of origin. breed. herd size. number affected and 
season. All variables with a P-value of :S 0.20 from the univariate analyses were offered to the 
multivariate logistic regression for model building. Multivariate logistic model with the MAP 
shedding status as outcome was constructed using fornard stepwise selection procedure. while 
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deviance was assessed using Akaike Information Criteria. Interaction hctv.een key variables 
was assessed using the same strategy. The adjusted odds ratios ,,ere estimated v.ith 95% 
confidence intervals (95% Cl). The Wald and likelihood ratio test and the I losmcr and 
Lemeshow Goodness-of-Fit test were used to assess the model fit. 
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RESULTS 
In total. 562 of the 1.684 (33.4~o) fecal samples from 42 of the 53 counties in ND 
submitted from 1995 to 2005 to NDSU-VDL. were diagnosed as rnlture-positive to MAP. 
Positive case reports varied from I to 86 (median=6) in the rnunties. Of the data with 
completed entries, 47.1 % of the cases were dairy (n= 197). while 52.9% (n 221) were beef 
breeds. Only the Holstein dairy breed \\as represented ( I 00%: rr 197 ). The beef breeds were 
Angus (49.3%; n=l09); Gelbvieh ( 16.3%: n=36): cross breeds (9.0%: n 20): Shorthorn (5.4%: 
n=l2); Limousin (4.1%; n=9): Simrnental (4.1%: n 9): Brahman (1.8%. n-4): Charolais 
( 1.8%; n=4); Hereford ( 1.8%: n=4 ): Black Maine. Corrient. Longhorn and Tarentaise-cross 
each represented 0.9% (n=2): and others constituted 3% (n 6). Bn:ed!-. classified as "uthers" 
included: bucking bull (I). Normande (I) and Saler (I). Because of smaller numbers of 
individual cattle breeds involved. it was not possible to run analysis on their influence on fecal 
shedding; instead they grouped together according to their use ( dairy or beef). 
Figure 3.1 shows the spatial distribution of MAP cases per county in ND (n=467) from 
1999 to 2005. The 1995-1998 (n=95) data were excluded due to missing county infonnation in 
their entries. 
Figure 3.2 shows the distribution by county of producers participating in the V JDCP as 
of March 22, 2007 (n= 173 ). A total of346 (91.8%,) positive cases were females and 31 (8.2%) 
were males; 185 case records did not specify gender. Of the 562 culture-positive cattle. 225 
(40%) had age infonnation missing. Twenty-li\e (4.4'X,) were -2 years. 83 (14.8%) were 3-4 
years and 229 (40.7%) were recorded as adults. 
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Figure 3.1: Spatial distribution by county of fecal cultur - p 1t1 e ca e f M oba t rium 
avium subspecies paratuberculo is infection in cattle in orth Dakota, 19 9 - 2005 (n- 467). 
Variations in the case reports by cattle type and year of reporting 1995 to 2 05 are 
given in Figure 3.3. As observed the proportion of po itive ca e betwe n the b f (52. % 
n=221 /418) and dairy breed (47.1%, n= 197/418) were comparable although the bred entrie 
for 144 other animals were missing. Eighty-eight percent (n- 94/562) of MAP ca were 
reported from 2001 to 2005 following launch of the Voluntary Johne' Di e e ontrol 
Program in 2001, while 58% of cases (n=327/562) were reported in 2004 and 2005, hawing 
a very marked increase in the last two years. 
Figure 3.4 shows the cattle type cumulati e incidence of MAP per 10 cattle initially at 
risk in D by year of reporting. 
Figure 3.5 shows a monthly relationship of culture-po iti e re ul to total ubmi ion 
over the same period. 
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Figure 3.2: Distribution by county of producer participating in the orth Dakota Voluntary 
Johne's Disease Control Program a of March 22, 2007 (n= 173). 
Figure 3.6 describes the variation in the monthly trend in the mean numb r of culture-
positive MAP cases reported from start of the program in 2000 to 2005 n=50 detailed 
information missing [ n=54] for 1995-1999). 
Trends show the highest mean number of positive MAP case wer diagn ed during 
early spring and late winter (38 and 25%, respecti ely compared to ummer and fall 19 
and 18%, respectively· P=0.0091 · Table 1). Further examination of ubmi ions r ealed 
higher fluctuations in the number of case during May-July and o ember- cember 
showing yearly influence. 
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Figure 3.3: Spatial distribution by count and year of reporting of ti al culture-po iti e 
cases of Mycobacterium avium subspecies paratuberculo i infection in cattl in rth 
Dakota, 1999 - 2005 (n=467). 
At the univariate level, hedding statu among MAP-infected cattle was found to b 
significantly associated with herd ize gender type (dairy/beef) and e n (P<0.05· able 
1 ), while age category was not (P>0.05). Details of the results from the tabular and 
univariate logistic regression analyses are gi en in Table 3.1. The final multi ariate logi tic 
regression model retained only two of the original ariable cattle type dairy/b ef) and 
season. Of these variables, the interpretation of their parameter e timate and e timated 
odds ratios suggested a strong association with shedding of MAP. In the final model ef 
cattle were associated more strongly with high shedding of MAP than dairy cattle ("£2dr = 
5.8 OR=2.13; 95% CI=l.3-3.5· P=0.016) de pite higher case reports from the dairy 
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breeds (Figure 3.2). hedding variation was ignificantl differ nt within n 
(i3dFl 1.6, OR=3.8; 95% CI= l.2-2.3· P=0.009). Th total ample iz u d ti r thi 
was 215, concordance was rel a ti ely high at 61.5%, a tual mi I 
24.4% and the Hosmer and Leme how Goodn -of-Fit t 
the model fit was adequate(:( = 1.37 P=0.5029). 
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Figure 3.4: Distribution by breed and year of reporting of fecal culture-po iti e c e of 
Mycobacterium avium subspecie paratuberculo i infection in cattle in orth Dakota 1995 -
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Table 3.1: Univariate logistic regression analysis of associations hctween shedding status 
(high or low) of MAP infected cattle and ,arious risk factors ( herd si/e. gender. season. 
cattle use, age and number reported sick in herd). 1995-2005. 
Variable 
Herd size 
Gender 
With season variability 
Comparison between seasons 
Cattle use 
Age (years) 
Category 
Large(> 144) 
Small(< 144) 
Female 
Male 
Winter 
Spring 
Summer 
Fall 
Winter vs Fall 
Spring vs Fall 
Summer vs Fall 
Beef 
Dairy 
··J 
2-3 
>4 
No. tesled 
46 
42 
317 
24 
163 
133 
87 
80 
19:'i 
169 
8 
61 
I 'i6 
l'cm~nl high 
MAI' ,hedder 1 (_0 o_) 
:'i2.2 
23 .8 
")' ' __ ,.J 
41.7 
17.2 
·'·' .8 
24 I 
2U 
0 436 
29.7 
I 6 6 
62.~ 
27.9 
28.2 
--· --------
l'-\aluc 
---· --" - - -~--
0.006 
0.043 
0.009 
() ):'i7 
0.003 
0 003 
O I I I 
Number individuals <::20 l 16 34.:'i O 969 
Reported sick in herd3 >20 --~7~ _ ._ .~4 2 _ _ ______ -~--
1High shedders: defined as high shedders if the MAP colonic, from cultured fe<.:e, look b, than two week, 
to show visible colonies. 
2Herd size: herds with> 144 heads of cattle considered large and · 144 ,mall 
3Number of individuals reported sick in herd: number farmer rerorted with ,imilar ,ign, al the time of 
diagnosis. 
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DISCUSSION 
Monitoring and Surveillance Systems (MOSS) arc essential for detcnnining the 
direction or effectiveness of disease control or eradication strategy. Re, iew of laboratory 
data from an ongoing control program is one of the MOSS tools used. This present study 
evaluated the status of MAP infection in cattle in ND. using information retrieved from the 
veterinary medical records of NDSU-VDL. The North Dakota Voluntary Johne's Disease 
Control Program is one of many similar ongoing programs in the l JS (l JSDA-APHIS. 
2006), and is based upon early detection and removal of inkded animals. lo our 
knowledge, this is the first study to use laboratory data to assess the progress of the bo\'ine 
Johne's disease control program in ND. 
This study gives insight into the qua! ity of data captured and I imitations of using 
such data for disease monitoring purposes. The obsern:d results could ha, e been biased by 
lack of standardization of sample submissions because it was ,oluntary. l·urthcrmorc. it 
could have been influenced by the continued impro,ements in the laboratory diagnostic 
protocols. Differences in cattle type (dairy/beef) submissions could have been influenced 
by other factors, such as variations in the farmers' interest. The sampling wa<; open to both 
beef and dairy. The state informed producers that they would be compensated by the 
federal government for fecal and serologic testing if they enrolled. and were also informed 
of the herd health benefits of controlling Johne's disease. Despite this. it is known that 
dairy cattle are more likely to be closely monitored than beef breeds. Likewise. producers 
are more likely to collect and submit samples when cattle are gathered. hence a seasonality 
bias. 
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This study demonstrated widespread distribution ( 42 of 53 counties) of MAP 
infection in ND (Figure 3.1 ). suggesting existence of probable reser\'oirs and an endemic 
situation in the state. The appearance of an upward trend in the number of case reports 
could not be directly linked to increases in the rate of new infection without considering 
other factors, such as increased producer awareness and recruitment of new participants. 
Also, there was a correlation between distribution of cases by county ( Figure 1.1) and 
distribution of producers participating in V JDCP ( Fi gun: 1.2 ). with participating counties 
having more MAP cases reported than counties without participants. suggesting producer 
bias. In addition, it was evident that the lowest percent positive submissions occurred in 
2000, which was prior to the introduction of V JDCP. The majority of cases (88%. 
n=494/562) were reported between 2001 and 2005. following introduction of the V JDCP 
in 2001, suggesting that submissions changed with participation. This observation 
highlights the importance of V JDCP participation as a way of inneasing Johne's disea'>e 
testing. From the available data. it is not possible to explain the appearance of an upward 
trend in the case reports. There arc two possibilities: either there is a producer bia'>. where 
there is increased interest and participation. or simply that there is a true increa'>e in the 
disease prevalence. 
Early identification of MAP clinical shedders remams difficult (Whitlock and 
Buergelt, 1996), partly due to low sensiti\'ity of the tests used and the presence of 
subclinically infected cows in the herds. both of which may substantially increa'ic risk of 
infection. Currently, available tests to detect MAP-infected animals produce many false 
negatives, particularly in subclinically infected or low-MAP fecal-shedding animals. thus 
making their interpretation and utilization in control programs challenging (Tiwari ct al. 
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2006). In the NDV JDCP serial testing was adopted. with either the whole herd or 
percentage of the herd being screened first with ELISA. and then followed by fern! culture 
of positive samples. 
It has been suggested that the prolonged pre-clinical phase of lifelong MAP 
infections and the poor perfonnance of diagnostic tests make identification of clinical 
shedders difficult. As a result. the susceptible population is exposed to suhclinically 
infected cows, which are the main risk factor in the spread of the disease (Wells and 
Wagner, 2000). 
The spatial-temporal distribution of MAP cases (not shown) showed ca<;cs 
clustered in the southwestern part of the state. while the more recent cases were reported 
mainly in southeastern ND. The direction of mo\Cment of the disease across the state is 
possibly linked to increased producer awareness and submissions from ni.:wly recruited 
participants. Interestingly, case reports and cumulati\e incidence of MAP infection in dairy 
breeds peaked every three years ( 1995, 1998. 2001 and 2004 ). This observation was more 
pronounced in dairy than beef cattle. It was not possible to establish whether this increment 
was an actual or an apparent increase in case-detection rate. J lowen:r. from trends in our 
results, a three-year MAP infection cycle appears to exist in dairy herds in ND. Producers 
received incentives (testing) annually. and therefore monetary incentives should not have 
influenced the three-year trend. 
The main limitation of this study was lack of baseline information on the reference 
population. In addition, no information was provided on the sampling criteria. although we 
were told that any herd was eligible for entry into the program. 
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Because results of this study do not condusiwly deline \\ hcther ne,\ cases resulted 
from more farmers responding to the program or an actual increase in number of cases. an 
annual review of control strategies in ND is highly recommended. The comparable 
distribution of case reports between beef (52%) and dairy breeds (48%) in ND (Figures :u 
and 3.4) suggest the two breed groups were equally susceptible: however. when 
considering the reference population. the MAP cumulative inridem:e was higher in dairy 
than beef breeds. 
The occurrence of infection in both cattle production systems supports the notion 
that MAP can cause serious economic losses in both dairy and beef cattle ( Benedict us ct al. 
I 987~ Johnson-Ifearulundu et al. 1999: Roussel ct al. 2005 ). 1 lowc\'er. the significantly 
higher MAP shedding rates in infected beef than dairy rnttlc (lahle 3.1) could he linked to 
poor hygiene conditions of beef fam1s (Roussel ct al. 2005 ). calves suckling infected cows. 
common beds or feeding. 
In this study infection rates were higher in older animals (71 % ) than younger ones 
(29%). Also, larger herds were observed to have more heavy MAP shedders than smaller 
ones. This agrees with 1996 Dairy National Animal J lcalth Monitoring System's 
(NAHMS) study (Johne's disease on U.S. dairy operations. USDA: APIIJS:VS. CEAlf. 
National Animal Health Monitoring System 1997: Fort Collins. Colorado). which reported 
that larger herds (>300 cows) were more likely to he infected than smaller herds (<50 
cows). In the present study. the presence of high shedders in larger-sized herds could be 
due to increased close physical contact between individual animals. leading to more 
effective transfer of infection to non-infected animals in large herds. Also. sanitary 
practices to decrease the risk of new MAP infections arc difficult to implement around beef 
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cattle compared to dairy cattle (Goodger ct al. J 996: Johnson-I frarulundu cl al. J 998 ). 
While sanitary practices may be mandatory to control mastitis in dairy operations 
(Goodger et al. 1996; Johnson-lfearulundu et al. 1998). that is not the case for hccf herds. 
making these particular groups more vulnerable to infection than dairy cattle. 
Additionally, at a univariate lc\el. there was a signiticant difference 111 the 
proportion of female cattle (93%) that v.erc infected compan:d to males (7%). howcwr. 
high shedding was observed more in males than females ( P 0.041 ). This could he 
attributed to differences in the submission rates. Then: arc fc\\er hulls than cows in hoth 
beef and dairy herds, and most dairies use artificial insemination so they have few bulls. 
This may account for the difference in proportion of infected females as compared to 
males. 
Although in this study the shedding status was higher in animals four years of age 
or older, the differerence was not statistically significant (P,,,0.05). This is contrary to 
several earlier studies in which high shedding was associated with inerea-;ing age. Several 
studies (Chiodini, 1996; Nielsen and Ersholl. :2006: \Velis and Wagner. :woo) reponed that 
cattle infected with MAP have a long prepatent period in which no shedding of the 
organism occurs, which is followed hy intennittcnt then continuous shedding. increa. .. ing in 
volume as the disease progresses. 
Seasonality in the shedding pattern of MAP was also detected. with higher 
shedding in colder months (winter and spring) compared to warmer months (summer and 
fall; Figure 3.4 and Table 3.1 ). in spite of most samples being submitted in fall. This agrees 
with other studies that found higher MAP incidence during the winter months (Crossley ct 
al. 2005; Harris and Barletta, 200 I). A likely explanation for the difference in incidence 
I 06 
and shedding status (high or low) between spring and summer could he the effects of o,er-
wintering on body condition and/or cal\'ing season stress and lactation. Stress 
compromises the immune system and results in higher lc\·els of disease in many 
mammalian species in the breeding season ( Nelson and Demas. J 996 ). Other researchers 
(Judge et al. 2005), have downplayed this winter and spring stress hypothesis. and attribute 
increased MAP case reports to increased case dcte1.:tion as a result of increased attention 
paid to cattle during spring rather than an actual increase in MAP prevalen1.:e. This 1.:ould 
explain observations in this study. The high proportion of \1AP infection in winter and 
spring is also in agreement with the seasonal \ariation of other cnteric animal disea-;es 
(Scott et al. 2006). 
The main limitations of this study wen: lack of control of quality of data recorded 
(missing variables), limited access to management and ecological data and lack of 
information on the reference population. Access to these data could ha\'e pro\'ided \'ital 
information to better explain the host-en\'ironment-agent interactions during spring. This 
study could have been further limited by the low sensiti\ ity (:18'~v) of the kcal culture test 
used, as well as possible impro\'ements in the laboratory protocols as 1.he lab focused more 
on the program. Rapid and more sensiti\'C procedures (with a sensitivity of 93 to 96%) 
using immunomagnetic bead separation and real-time P( 'R for diagnosis of clinical and 
subclinical Johne's disease (paratuberculosis) from milk and/or fecal samples from cattle 
and American bison have been reported ( Khare ct al. 2004 ). These methods ( Khare ct al. 
2004 ), have been reported to be \'cry useful and cost-dkcti\'e compared to bacteriological 
culture, which is constrained by time. labor. and expense under diagnostic laboratory 
conditions. 
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CONCLUSION 
This study demonstrated widespread occurrence of MAP and documented some 
risk factors for MAP shedding in dairy and beef cattle in ND. Counties with producers 
participating in ND Johne's Disease Voluntary Control Program reported more MAP cases 
than counties without participants. The study also pro\'ided information on the progress of 
the control programs for bovine Johnc's disease in ND. helping to identify some critical 
areas for further research and inter\'ention. This study further justifies the retrospective 
examination of laboratory data to strengthen and add valul' to national disease monitoring 
and surveillance efforts. It also recognizes serious limitations of this data and recommends 
that new efforts be made to impro\'e the value of data for stall' and national reporting. 
Endnotes 
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PAPER 4 
TYPING OF MYCOBACTERIUM AV/UM SUBSPECIES 
PARATUBERCULOSJS STRAINS FROM SYMPTOMATIC 
AND ASYMPTOMATIC CATTLE 
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ABSTRACT 
Background: Mycobacterium m·ium suh.,pl!Cies pamtuhercu/o.,is (MAP) 1s an 
intracellular bacterial pathogen that causes Johne·s disease. also known as 
paratuberculosis. This disease is a chronic inflammation of the intestine of cattle. sheep 
and other ruminant animals. Crohn ·s disease is a form of chronic inflammatory disease of 
the intestines in humans. An increasing human health concern is the potential link between 
Johne's and Crohn's disease: howe\er. this hypothesis is still under dehatc. The typical 
symptoms of paratuberculosis include slowly progressin: wasting and diarrhea. It is 
reported that both symptomatic and asymptomatic cattle shed MAP in feces. Ohjectin: 
The goal of this study was to analyze MAP strains isolated from symptomatic and 
asymptomatic cattle. as well as humans. using various biochemical typing techniques and 
to investigate how variations in hactcrial and non-hactcrial factors could predict if an 
animal would be symptomatic or not. This study is essential in order to gain a better 
understanding of the pathogenicity and \ irulence of MAP strains. as well as the 
relationship between MAP and Crohn · s disease. Methods: In total. 120 ( one hundred and 
eighteen bovine MAP isolates and additional t\\o human clinical) isolates were analyzed 
by methods of high performance liquid chromatography ( IIPLC ). gas chromatography 
(GC). and mass spectrometry (\1S). Statisitcal analysis including chi-square and logistic 
regression was done using Epi Info \ersion 1.5.1. The symptom status of animals was used 
as the outcome variable and \\as binary (asymptomatic and symptomatic). Results: At the 
univariate logistic regression analysis. the symptoms status of isolates was significantly 
associated with mass spectra patterns (OR 3.7. 95% Cl 1.7. 8.2: p ·0.00097). grow1h rate 
(OR= 11.0. 95% Cl= 4.5. 26.8: p ,().()001 ). and shcdder status (OR 1.4. 95% CI= 1.6. 
1 l .S 
7.3; p = 0.00127). Howe\'cr. the association between symptoms status and IIPLC and GC 
patterns was not significant (p > 0.05 ). Conclusion: O\'erall. the study demonstrated that 
bacterial and non-bacterial factors of MAP strains could predict if the source animal would 
be symptomatic or asymptomatic. These data could play a significant role in the design of 
future diagnostics, therapeutics and rnccines f<.H Johnc's and Crohn's diseases. 
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INTRODUCTION 
Mycobacterium avium suh.,pecie., paratuhercu/osi., (MAP) is a causatin: agent of 
paratuberculosis ( or Johne's disease). described as chronic enteritis of cattle. sheep. goats 
and other ruminant animals (Chiodini ct al. J 984: Sweeney ct al. 1996 ). It reported that 
MAP is an economically important bacterial pathogen that causes considerable economic 
losses in domestic livestock (Manning and Collins. 2001 ). Studies have also implicated 
MAP in cases ofCrohn's disease in humans (Naser ct al. 2004). an inflammatory disease in 
which patients suffer from chronic enteritis and intestinal pathology that is similar to 
Johne's disease in cattle. Although several lines of evidence (Dalziel. 191 J: El Zaatari ct al. 
2001; Naser et al. 2004: Clancy ct al. 2007: lJzoigwc ct al. 2007) support the causal role of 
MAP in Crohn's disease. this causal link has not yet been proven. The typical symptoms of 
Johne's disease arc slowly progressi\'C wasting ( cmanciation) and diarrhea. which 1s 
intermittent at first. becoming progressively more severe until it is constantly present m 
cattle. Besides diarrhea and weight loss. infected animals show decreased productivity. 
increased infertility and susceptibility to other infections. which may eventually lead to 
animal death (Merkal cl al. 1975 ). Researchers have shown that <.:ows become infected 
early in life through ingestion of MAP from a contaminated cm ironment. referred to as 
transmission via fecal-oral route. and infected animals may remain in the asymptomati<.: or 
subclinical stage of the disca-;c for several years (2-5 years). following initial exposure of 
the bacteria (Larsen ct al. 1975 ). It is known that paratuhcn.:ulosis can exist undetected in a 
herd for years. unless the animals arc tested ( Koets ct al. 2002 ). Studies ha\c shown that a 
phase of multiplication of \1AP begins in the \\alls of the small intestine. during the early 
phase of infection. and depending on the resistance of the animal. this infection is 
I I 7 
eliminated or the animal remains infected as a healthy carrier ( Larsen ct al. 1975 ). In only a 
few animals carriers, the multiplication of MAP at a later phase leads to the extension of 
intestinal lesions, interference with intestinal metabolism and development of ()\'Crt clinical 
disease. Koets et al. (2002) reported that both peripheral and intestinal cell-mediated 
responses are decreased in symptomatic animals compared to asymptonwtic animals. 
Many authors (Abbas et al. 1983: Whitlock ct al. 1986) reported that the proportion of 
animals in the asymptomatic categories outnumber symptomatic cows in most herds with 
paratuberculosis. 
As seen with most living bacteria. cells of MAP arc surrounded by a cell wall 
responsible for providing their shape. as well as protection to the cell against physical and 
chemical factors (Hett and Rubin. 2008: Brennan. 2003: Chi mote and Baner:jee. 2008 ). The 
thick waxy nature of the mycobacterial cell wall makes it a highly impenneahle outer 
surface, which enables mycobacteria to survi\e in the prcscm.:e of antibiotics and harsh 
environmental conditions ( Hett and Rubin. 2008: Brennan. 200J ). The mycobacterium cell 
wall partly resembles a Gram-positive wall. hut is unusual in ha, ing a layer of lipid 
(mycolate esters) (Daile and Draper. 1986). which is n:ry tightly connected to the 
peptidoglycan and arabinomannan inner layers of the cell wall ( Minnikin 1982). Mycolic 
acids are recognized as high-molecular-mass 3-hydroxy. 2-alkyl-branched fatty acids found 
in the cell wall of all .\{rcohacterium species ( Minnikin 1982 ). The lipid component of 
MAP cell wall. specifically the mycolic acid component has been analyzed hy use of 
various biochemical typing techniques. It is reported that the major slowly growing 
pathogenic mycobacteria and .\~rcohacterium gordonae has been identified by high-
performance liquid chromatography of their rnycolic acids (Butler and Kilburn. I 988 ). 
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Many authors (Butler et al. 1991: 1996: 1999) have reported the analysis of mycolic acid 
using high-performance liquid chromatography (IIPLC) and p-bromophcnacyl bromide 
derivatizing reagent for UV detection. Parrish ct al. ( 2007) demonstrated a rapid. 
standardized method for determination of .\~rcohacteriwn ruherculosis drug resistance and 
susceptibility by use of high-performance liquid chromatography (IIPLC)-bascd 
quantitation of mycolic acids. Lctinann ct al. (2004) reported the use nf matrix-assisted 
laser desorption ionization-time of flight mass spectrometry ( MALDl-lOF MS) alter base-
specific cleavage of PCR amplified and in vitro-transcribed the I 6S rRNA gene (rDNA) 
for the identification of mycobactcria. 
Previous works reported that the bacterial cell ,,:all composition is not static and 
several factors such as physiological and/or environmental conditions aftc<.:t the chemical 
composition of mycobacterial cell wall ( lie and De Buck. 20 I 0). The chemical 
components and the assembly of the different ma<.:romolcculcs that make up the bacterial 
cell wall arc modified during <.:ell growth and morphogenesis. It is reported that 
mycobacteria have B-lactamascs. enzymes asso<.:iatcd with <.:ell wall monitoring and 
remodeling (Flores et al. 2005a : 2005b: Md)onough ct al. 2005: Wang ct al. 2006). 
Toriyarna et al ( 1978. 1980) reported the cffe<.:t of growth temperature on mycolic acid 
composition and synthesis. Their results showed that an increase in growth temperature of 
Mycohacterium phlei leads to an enhanced mean chain length of mycolic acids (Toriyama 
et al. 1978. 1980). According to Laval ct al. L:!00 I). examination of the MALDI ma'is 
spectra demonstrated that the chain lengths of the ,arious myrnlates correlated with the 
growth rate of mycobactcrial strains. Shin and colleagues ( 2006) conducted a study on the 
the phenotypic screening of a library and identified disruptions of genes inrnl\'ed in iron. 
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tryptophan, or mycolic acid metabolic pathways that displayed unique gro\',1h 
characteristics. These researchers identified potential virulence detcm1inants representing 
novel functional classes that could be necessary for mycobactcrial sun ival during infection 
and could provide suitable targets for \accine and drug devdopmcnt against Johnc's and 
Crohn's diseases (Shin et al. 2006 ). 
Molecular typing methods haw been used by researchers to detect genetic \ ariation 
between different isolates of a bacterial species. Numerous molecular techniques have 
repeatedly been used to analyze the mycobacteria organisms. including PHiF (Sevilla et 
al. 2007) and RFLP (Whittington ct al. 2000). Pulsed-field gel electrophoresis (PHiE) is a 
molecular technique in which the entire genome can he n:presented as a distinct pattern of 
DNA restriction fragments (Hughes et al. 2001 ). Mira et al. (2002) rcpor1cd that DNA 
rearrangements arc responsible for genomic diversity in microbial syskms and usually 
contribute to the fitness of a pathogen in specific microcnvironmcnts. Previous researchers 
(Oliveira ct al. 2003) reported that examining restriction fragment kngth polymorphism in 
the h.\p65 gene showed greater \ariahility and suggested that thcrc are distinct lineages of 
strains that infect animals and strains that infc<.:t humans. A study hy Wu ct al. (2006) using 
comparative genomic hybridization to analyze the <.:ontcnt of thc ,\I paratuhert"ulosis 
genome identified large regions that rnuld cxplain its diffcrcntial , irulcn<.:c wmpared to 
that of the closely related .\I m·ium suhsp. m·ium Shin et al. ( 2006) reported that genes 
may be involved in different virulen<.:e me<.:hanisms. According to Djonne ct al. (2005 ). 
variation in virulence between different isolates of a bacterial species can he caused h~ 
genetic variation that is detected by phenotypic or genotypic characterization. 
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It is known that the mycobacterium cell wall mycolic acid is not static. but varies 
among MAP isolates. Likewise. studies using molecular typing techniques have shown that 
the genetic composition of MAP isolates varies. The goal of this study was to examine the 
differences in the mycolic acid compositions of MAP isolates from symptomatii.: and 
asymptomatic cattle. in order to obtain a better understanding of the various factors 
affecting the manifestation of symptoms in infci.:ted animals. as well as the differences in 
virulence and pathogenicity of MAP organisms. In addition. this study investigated 
whether the symptom status of animal is associated with growth rate. shedder status and 
mass spectra patterns of MAP isolates. The study also compared the biochemical profiles 
of isolates from Crohn·s and Johne·s disease. 
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MATERIAL AND METHODS 
Growth and identification of bacteria isolates 
A total of 120 [one hundred and eighteen bcl\'ine MAP isolates and additional two 
human clinical (ATCC 43015. 43544)1 isolates. were used in this study. The human MAP 
isolates were purchased from the American Type Culture Colle<.:tion (ATCC). Manassas, 
VA. The bovine MAP ( 66 asymptomatic and 52 symptomatic) isolates were ohtained from 
the North Dakota State Veterinary Diagnostic Laboratory (ND- V DL). Fargo. North 
Dakota. The MAP isolates were grown on llerrold's egg yolk medium (I U-:YM) slants with 
mycobactin J (HEYMJ). Bacteria from IIEYMJ slant were inoculated into Middlebrook 
7H9 liquid media (Becton, Dickinson. Sparks. Md) supplementrd with ADC (alhumin. 
dextrose, catalase) enrichment (Sigma Chemical Co .. St. Louis. Mo.). and mycohactin J 
(Allied Monitor Inc .. Fayette. Mo.). and incuhated at 37°C for up to 16 weeks. Based on 
results of culture on Herrold's egg yolk medium ( IIFYM.I) slants. all isolates were 
classified in two categories based on growth rate categories: group I ( slov, growth or 
growth in> 2 weeks) and group 2 (rapid growth or growth in· 2 weeks). 
The identity of all MAP isolates from the cultures \\as conlirmed using the IS900 
insertion sequence. PCR analysis for lS900 \\a'- carried out hy using the primers and PCR 
conditions described by Ayele et al. (2005 ). Briefly. 50 µ1 of sterile distilled water was 
inoculated with a single colony of a positive culture. DNA v.as extracted from the bacterial 
suspension by heating it at 1 OO"C for 20 min and then centrifuged at 16.000 x g for 2 min: 
2 µI of the supernatant was added to the amplication mixture. The reaction mixture wa'i 
analyzed using a Perkin-Elmer 480 thermal cycler. Llectrophoresis was performed in a 2% 
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agarose gel in IX Tris-borate-EDTA buffer. The gels were stained in ethidium bromide (5 
µg/ml) and visualized by UV light transillumination. 
Gas chromatography (GC) anal)·sis 
Preparation offauy acid methyl esters f F·L\ll:'.'-,') MAP cell wall myrnlic acid was 
extracted and esterified by use of protocol pre,iously described by Minnikin et al. ( 1980). 
In brief, one-milliliter aliquot of the bacterial culture (ODqo of l .J 1.4 that corresponds 
to 3 x 109 - 5 x 109 CFU/ml of cells) was transfrrred to a ne\, tube and centrifuged at J.500 
x g for 20 min. The cell pellets was esteritied by mixing with 2 mis of transesterification 
reagent, methanol/toluene/H 2S04 in the ratio of JO: 15: I. The samples were heated at 85 °C 
for 16-18 hours in an oil bath. Then. 2 mis ofchloroti.lm1: hexane (4:IJ was ac.lc.led to the 
cooled sample. This was tiJllowed by addition of 1 ml of (U M phosphate huller (42.57 g 
ofNa2HP04 and 12.0 g of NaOII per liter of distilled water (pH 11 to 12). Samples were 
centrifuged (3.000 x g. IO min. 4cc ). and the lower organic layer rnntaining the fatty acid 
was transferred to a clean tuhe. The extracts \\Crc e\aporated to dryness under a stream of 
nitrogen at 37-42°C and stored at occ. 
Ana~vsis of/atty acid methyl e,ten hy (,( · The dried sample of fatty acid methyl 
ester was resuspended in I 00 µl of chloroform. The fatty acid methyl esters. mycolic acid 
cleavage products were analysed on HP-5 column (}Om hy 0.25 mm I inside diameter] and 
0.32 µM df (Agilent J& W Scientific. Folsom. CA. l :SA). The column wa-; inserted in a 
GC-2014 Schimadzu gas chromatograph (Shimadzu Scientific Instrument. Inc. Lancxa. 
KS). equipped with a flame-ionization detector. an autosamplcr ( AOC-20i autoinjcctor 
Schimadzu) and a computer softv,are s!stem (micronpc Client Pro585). The column wa<; 
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then programmed at 225°C to 300cc at I O'C min and maintained at 300"( · for :;o min. The 
injector and detector temperature was 300°C. The carrier gas was helium ,,.ith a flow rate 
of approximately l.96ml/min. The pressure was maintained at 225.8 kPa. The peaks on the 
chromatograms were identified by matching peak retention times with those of fatty acid 
methyl ester standards (Ultra Scientific Analytical Solutions. North Kingstown. RI. USA). 
Each sample was analyzed three times with identical results. 
HPLC and mass spectromet11· anal~·sis 
Preparation of hromophenyl esrers of mycolic acids Fatty acids arc extracted. 
derivatized and analyzed by a modification of the methods pre\'iously dscrihed elsewhere 
(Butler and Kilburn. 1988). Bacteria were hanested by centrifugation (3.800 • g. 20 min. 
4°C) and washed twice with middlebrook 71!9 broth. Bacterial pellets were resuspended in 
an appropriate amount of the same medium to obtain an Ol)q(, of 1.3 I .4. which 
corresponded to 3 x I 09 - 5 ,. I 0'1 CFl 1ml 1• Three milliliters of this suspension was 
transferred to a clean screw cap culture tube ( 1J by 100 mm) and centrifuged (J.800 ,,, g. 
20 min. 4°C). The cells were finally resuspcndcd in 3 mis of stcrilc distilled water and 
autoclaved for 30 min at 121 °C and I 5 lblin 2. The autoclaved supension of cells were 
centrifuged (3.800 x g. 20 min. 4''(') and the \\ater v,as rcmon:d with a capillary pipette to 
ensure that a minimal amount of supernatant fluid v,as left with the cells. Fatty acids. 
mycolic acids and alcohols \\ere liberated from each strain sample by saponification using 
25% (w/v) KOH in ethanol water (I: I ,o) vol) at 85''C. lhe extract wa-; then treated with 
chlorofonn. acidified v. ith concentrated IICI. dried. and suhse4ucntly treated with 
potassium bicarbonate and dried again. hir each strain. an aliquot of the mycolic acids 
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extract was transformed to p-hromophenacyl Jeri, atives. hy tn:atrrn:nt with I 00 µI p-
Bromophenacyl/crown ether mix ( Pierce Chemical Co.). followed hy heating at 8S°C for 
20 min. Sample was filtered and the supernatant e, aporated under vacuum. 
Analysis ofp-hromophena£yl es/as o/ mycolic acid, hy IIPI.C-.\I.\. Ahout IO mg 
of dried mycolic acid bromophcnacyl ester was redissohed in 2 ml of chlorofonn (UC-MS 
grade) and serially diluted to a l µM concentration and l O µI of the solution were analyzed 
by HPLC and Mass spectrometry. For analysis using IIJ>l.C. the p-hronrnphcnacyl 
derivatives of the mycolic acids were separated in a IIPLC system (Waters Associates) 
equipped with an UV/visible detector measuring ahsorham:e at 254 nm. A reverse-phase 
Cl8 column (Nova-Pack 60A. 4 µm. 3·9x7S mm: Waters Associates) was used in the 
system. The column was equilibrated ,.,ith 91 °u methanoJ1()<'10 d1loroform. Alter injection 
of the sample, the gradient was changed linearly to 30%, methanol/70% methylene 
chloride. The total run time was 30 min. at a total Ihm rate of I ml min 1 ( Butler ct al. 
1986). A high-molecular-mass standard (Rihi: lmmunoChem Research) \\as used as a 
standard. The HPLC patterns were interpn:ted hy comparison "ith standard reference 
chromatograms of known mycolic-acid-containing mycohacteria ( Butler ct al. 1986: Butler 
and Guthertz, 200 I). For sample analysis hy use of mass spectrometry. IO µI of I µM 
concentration of the solution the my colic acid hromophenacy I esters in chloroform was 
analyzed by use of BioTOI· Flectrospray Ionization I imc-of-l·light (!:SI-TOI·) Ma-,s 
Spectrometer. a'isociatcd with Bruker Daltonic Data Analysis ( Bruker Daltonics BioTOF 
Billerica. MA. L'SA). Each sample v.as analyzed in triplicate v,ith iJi.:ntical results. 
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Statistical analysis 
The results of this study wen: analyzed as desnibed by Niemann ct al. ( J 999). Data 
were analyzed using the software package Fpi Info ,ersion J.5.1. Catcgorii.:al ,ariablcs 
were compared by using x2 test or Fisher's exai.:t test. l lni,ariate logistic regression test was 
performed to determine whether i.:hangcs in IIJ>LC protilcs. (iC profiles. mass spectra 
patterns, growth rate and shedder status wen: associated with changes in symptom status of 
the animals. 
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RESULTS 
Table 4.1 shows the relationships between symptom (symptomatic or 
asymptomatic) status of .\-fyc:ohac:terium m·ium subspecies paratuhercu/osi.1 ( MAP) 
infected cattle and other variables (HPLC. GC and mass spectrometry patterns of isolates. 
shedder status and Grow1h rate status of animals). 
Table 4.1: Univariate logistic regression analysis of assouations heh,een symptom 
(symptomatic or asymptomatic) status of MAP inlcded c.Jttk and other \ ariahlc factors 
(HPLC. GC, mass spectrometry patterns of isolates (OR - ?t.7. 95°00 Cl 1.7. 8.6). sheddcr 
status (OR= 3.4, 95% CI= 1.6. 7.?t) and growth rate status of Jnimals (( )R 11.0. 9Y% CJ 
= 4.5, 26.8). 
----· ----- --"- -- ---
Variable Category No of Isolates from lsolaks from df P value 
isolates asymptomatic symptomatic 
cattle(%) cattle(%,) 
---~ ----- -- ----
GC patterns GCJ 73 58.9 41.1 0.4 
GC2 45 51. I 48.9 
-·----- -- ------- -- , ---
HPLC HPl 64 57.8 42.2 0.7 
patterns HP2 54 5J.7 46.J 
---------~----- ---
-·-----· --------
Mass MS! 47 74.5 25.5 0.00097 
spectrometry MS2 71 43.7 5(d 
Patterns 
-- -
----------
Growth rate Slow growers 55 8J.6 16.4 • 0.0000 I 
Rapid growers 6J 3 I. 7 68.3 
--- -
- -· ·~------- --- . -
Shedder Low shedder 65 69.2 30.8 (l.00127 
status High sheddcr 53 J9.6 60.4 
Figures 4.1-4.6 show c:-.amplc.., of the n:..,ult.., of gas c:hromatography analyses of 
MAP isolates from symptomatic and as~ mptomatic: cattle..:. The ( iC results revealed the 
presence of identified and unidentified peaks. The peaks with retention times of 
approximately 1.40. 2.07. 3.J?t. 9J4 min and 16.2.5 min corresponding to C11ir,. C1kri. C2ur1 
and C 24 0 methyl esters respccti\ely \\Cre ohscned. Other unidentified peaks with retention 
times of 3.07. 3.65. 4J6. 4.59. 5.91. 6.13. 6.85. 9.09. HU. 12. IJ. and 16.8 I min were also 
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observed. Again we ob erved that ome i late po d 14 fatty 
acid), while some others do not. Based on that ob rvation w cl ifi d th 
aicd). In general, the GC results did not how any significant differen 
the slow and rapid growing bo ine MAP i olate . 
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Figures 4.7 and 4.8 how re ults for two human ymptomatic MAP i olat . 
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Figure 4.2: GC analysis of a bovin MAP i olat which w 
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yrnpt m tic and bel ng in 
Figures 4.9-4.16 how example of th high performance liquid chromatographic 
patterns of MAP isolates from symptomatic and asyrnptomati cattle di playin that 
indicate the presence of fatty acids. All sample h wed a ingl -clust r peak, consistin of 
one to fi e component peaks with r tention time of approximately 2.0min, 2.3min, 
2.5min 2.6min and 3.6min. B ed on thj ob rvation w cl ifi d th HP re ul into 
two groups: HPL 1 with ~ 3 component pe and HPL 2 with >3 component pea.ks . 
Figures 4.17 and 4.1 how re ul from two human ympt matic MAP i lat . 
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Figure 4.3: GC analysis of a bo in MAP i olate which was ympt matic and belon m 
the GC l group. 
Figures 4.19-4.24 how example of th re ul of th m pectra analy i of 
MAP isolates from asymptomatic and ymptomatic cattl which wer cl ified into tw 
groups: M I (ha ing hort carbon chain Jen hs and M 2 ha ing I n carbon chain 
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Figure 4.25 and 4.26 how the m 
MAP isolates. 
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Figure 4.27 shows the bar chart repre ntin th ur of MAP i lat cattle 
and humans) and th percentage of m pectra group M I or M 2) Ion in to ch 
source. 
Figure 4.28 shows the r Lationship betwe n th ympt m tat f i Late and th ir 
shedder and growth rate tatus. Ther i a sigruficant differ nee betw n ymptomatic and 
symptomatic MAP isolate . ach bar repre n th percent of MAP i late belongin to 
each category: bedder tatus low and high and owth rate tatus ( lo and rapid 
growers). 
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Figure 4.22: Mass spectral analysis of a bovine MAP isolate, which was symptomatic and 
belongs in the MC2 group. 
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Figure 4.24: Mass spectral analysis of a bovine MAP, which was symptomatic and belongs 
in the MC2 group. 
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DISCUSSION 
This study has investigated the phenotypic variability of symptomatic and 
asymptomatic MAP strains. For statistical analysis, the symptom status was used as the 
outcome variable. This means that we examined how changes in some variables (e.g 
growth rate, shedder status) would predict if an animal will have symptoms or not. Table 
5(i) shows the associations between grov.1h rate status (rapid or slow) of MAP infected 
cattle and other variables (HPLC GC and mass spectrometry patterns of isolates, sheddcr 
status of animals and symptom status of animals). In the statistical analysis. the symptom 
status of cows where the MAP isolates was rcco\'CreJ was used as the outcome \·ariable. 
MAP isolates from cows manifesting symptoms of Johne·s disease \Vere classified as 
symptomatic isolates, while MAP from asymptomatic cows were classified as 
asymptomatic MAP isolates. 
In this study, we examined the relationships between symptom status and the cell 
wall lipid of MAP isolates, by use of I IPLC. GC and mass spectrometry analysis of 
mycolic acid. Univariate logistic regression shows that the symptoms status of isolates was 
significantly associated with mass spectra patterns (OR=J.7. 95% CJ-= I .7. 8.6: p 
<0.00097), growth rate (OR= 11.0. 95% Cl= 4.5. 26.8: p <0.0001 ), and shedder status 
(OR= 3.4, 95% CI= 1.6, 7.3; p = 0.00127). However. the association between symptoms 
status and the HPLC and GC patterns was not significant (p > 0.05 ). All the MAP isolates 
showed a single-cluster peak by HPLC analysis. Similar findings were reported by Dei et 
al. (1999), whose studies show that within the cluster of peaks obtained by both M. avium 
and M paratuberculosis. they could not find a consistent difference typical of M 
paratuberculosis. The present study provided further confirmation of the fact that MAP 
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isolates either individually or classified into two group (symptomatic and asymptomatic) 
could not be distinguished by HPLC. 
Previous studies (He and De Buck. 20 l 0) reported that bacterial cell wall 
composition is not static and several factors such as physiological and/or environmental 
conditions affect the chemical composition of mycohacterial cell wall. In our study. the 
mass spectra results of mycolic acid of MAP isolates showed several ions ranging from 
m/z 271 to 1071, which were pooled into two categories: (i) the low mass region consisting 
of ions ranging from m/z 271 to 900 and (ii) the high mass region that consists of peaks 
greater than 900. MAP isolates were classified into two groups: MS l (consisting of peaks 
in only the low mass region) and MS2 (consisting of peaks in hoth low and high mass 
region). Our results indicated that 40 (56.3%) of symptomatic isolates produced a series of 
long chain carbon lengths mycolic acid (M2 pattern). compared to 31(43.7%) of 
asymptomatic isolates. On the contrary. 35 (74.5%) of asymptomatic isolates produced a 
series of short chain carbon lengths mycolic acid (MI pattern). compared to 12 (25.5%) of 
symptomatic isolates. These findings indicate that. the lmv mass region of the spectra is 
correlated with asymptomatic cow isolates. while the high mass region of the spectra is 
correlated with symptomatic cow isolates. Statisticaly analysis by univariate logistic 
regression shows that the symptoms status of isolates was significantly associated with 
mass spectra patterns (OR=3.7. 95% CI=l .7. 8.6: p <0.00097). and with growth rate (OR= 
11.0, 95% CI= 4.5, 26.8; p <0.000 I) and shedder status of isolates (OR= 3.4. 95% CI= 1.6, 
7.3; p = 0.00127). It is reasonable to believe that the rapid growth rate may have resulted in 
the shedding of high numbers of MAP isolates in feces. We further observed that 43 
(68.3%) and 9 (16.4%) of symptomatic isolates grew in Jess than and more than two weeks 
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respectively, while 46 (83 .6%) and 20 (31. 7%) of asymptomatic isolates grew in more than 
and less than two weeks, respecti\'ely. Based on these findings, we reasoned that the 
presence of longer carbon chain length mycolic acid and increased growth rate may 
provide additional advantage to the organism. such as enhanced capacity to cause disease. 
Our results bear close resemblance to those of pre\·ious works ( Laval ct al. 200 I ). These 
researchers (Laval et al. 2001) conducted a study using MALDI mass spectra and 
demonstrated that the chain lengths of the \'arious mycolatcs correlated v .. ith the growth 
rate of mycobacterial strains. Although slow growers. such as A~rcohactcrium tuhacu/osis 
and Mycobacterium ulceruns, produced a series of odd carbon numbers (C74-C82) of u-
mycolic acids, rapid growers synthesized both odd and even carbon numbers (Laval ct al. 
2001). 
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CONCLUSION 
Collectively, the results of our investigation showed that there was a significant 
association between symptoms status of isolates and mass spectra patterns. growth rate and 
shedder status, but not between symptoms status and the I !PLC and GC patterns of 
isolates. Furthermore, our data supported the hypothesis of strain sharing, intra-species and 
inter-species transmission. Additionally. our findings demonstrate the potential power of 
mass spectrometry to illustrate biochemical variation in MAP cell walls. Since previous 
studies reported that bacterial cell \Vall composition is not static and sncral factors such as 
physiological and/or environmental conditions affoct the chemical composition of 
mycobacterial cell wall, this observation could be further applied to our present study. 
Thus, it is important to note that bacterial cell wall mycolic acid analysis using 
biochemical methods may yield different results when analyzed under a different set of 
conditions. Overall, we are hopeful that new findings from this study should provide a 
better rationale for the future design of therapeutics for Johne's and Crohn's disea,;;es. and 
should lead to a better understanding of the association between MAP and Crohn·s disease 
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PAPER 5 
INVESTIGATION OF BIOCHEMICAL VARIATIONS OF 
RAPID AND SLOW GROWING MYCOBACTERIUM AV/UM 
SUBSPECIES PARA TUBERCULOSIS STRAINS 
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ABSTRACT 
Background: Mycobacrerium avium subspecies para111herrnlosis (MAP) is an organism 
that causes paratuberculosis (or Johne·s disease) in cattle and other ruminants and one 
purported to have a causal link with Crohn's disease in humans. Previous works have 
shown that the growth rates for MAP arc slow. with generation times of more than 24 
hours. Aim: The purpose of this study was to examine for associations between the 
biochemical variability of MAP strains and their gnm1h rate and presence of symptoms in 
the source cattle. Additionally. to obtain insights into the pathogenic mechanisms 
involving MAP in Crohn's disease. we compared the phcnotypic charactrristics of MAP 
strains isolated from Crohn"s disease patients with those from cattle with Johncs disrasc. 
Methods: Mass spectrometry of 122 [ one hundred and eighteen culture-positive bovine. 
three human (ATCC 43015, 43544, 49164), and one sheepJ MAP isolates were pcrfonncd. 
MAP isolates were classified as slow growers if the colonies appeared after 2 weeks and 
rapid growers if they grew in '.S 2 weeks. Epi Info version 3.5.1 was used to analyze for 
associations between the biochemical variability of MAP strains and their gro'.A.1h rate or 
presence of symptoms in source cattle using Chi-square and logistic regression. Results: 
Different mass spectra patterns were detected and categorized in two groups: IM 1 ( short 
carbon chain lengths) and M2 (long carbon chain lcngths)j. A significant difference (P< 
0.05) was observed between grow1h rate and symptom manifestation with 82. 7 % of rapid 
growers having symptoms in source cattle compared to only 17.3 % of slow growers. Also. 
univariate logistic regression showed a significant association between growth rate and 
presence of symptoms in source cattle (OR=l 1.0. 95% CI= 4.5. 26.8; p <0.0001 ). as well 
as between growth rate and presence of long chain length mycolic acid (M2) (OR= 4.4. 
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95% CI= 2.0, 9.8; p = O.ooo:n. Furthem1ore. the mass spectra 1( MS I) patterns of the sheep 
isolate were similar to those of bovine MAP strains. Conclusion: Data from this study 
provided an insight into the biochemical diversity among rapid and slow growing MAP 
strains and associations with manifestation of symptoms in source cattle. The similarities 
in mass spectrometry profiles between hovine. sheep and human MAP isolates could 
possibly explain the theory of strain sharing. intra-species and interspecies transmission, 
and particularly, the similarity between bovine and human MAP isolates may further 
support an association between Johnne·s disease and Crohn·s disease. The association 
between growth rate of MAP strains and presence of symptoms in source cattle. or 
between growth rate and lipid profiles pn)\'ided a hetkr understanding of the difl~rences in 
disease progression and pathogenicity of MAP isolates. This study provides useful data to 
assist in future management of animal farming operations and possihly in future design of 
diagnostics and therapeutics for both Johnne·s disease and Crohn·s disease. 
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INTRODUCTION 
Mycobacterium avium subspecies pura1uherculosis (MAP) is recognized as an 
organism that causes Johne's disease (paratubcrculosis) in ruminant animals. including 
cattle. Studies have shown that Johne's disease can , ary in sc, crity from inapparcnt 
infection to intractable clinical disease that C\ cntually leads to severe emaciation and death 
(Chiodini et al. 1984). A controversial theory is that MAP also plays a causal role in 
Crohn's disease, a chronic inflammatory disease of the intestinal wall in humans. with 
unknown etiology. Molecular evidence (Clancy ct al. 2007) and epidemiological evidence 
(Uzoigwe et al. 2007) have suggested a role for MAP in Crohn · s disease. It is reported that 
milk is a potential source of human exposure to MAP bacteria (Chiodini. 1989: Chiodini ct 
al. 1984). Several laboratory tests have been developed to aid in diagnosis of MAP 
infection; however, the cultivation of MAP from fecal specimens is recognized as a 
definitive and most frequently used diagnostic test in cattle ( Chiodini ct al. 1984: Colgrove 
et al. 1989), and is also regarded as the standard for comparison for nearly all other tests 
( de Lisle et al. 1980). It is reported that most Johne · s disease control programs use fecal 
culture test as the basis for making management decision (Thoen and Baum. 1988 ). 
A recognized feature of the genus mycobactcria is their slow growth rate on solid 
culture medium, which in addition. strongly varies in different species of the genus. 
Studies show that members of the slow growing mycohacteria include all highly 
pathogenic species such as M tuherculosis. J1. leprae and M. para!uherculosis causing 
tuberculosis, leprosy and paratuberculosis. respectively. while members of the fast growing 
mycobacteria are nonpathogenic and opportunistic species. such a, A1. sme~matis (Lewin 
and Sharbati-Tehrani, 2005). MAP is a slowly growing organism (>24-h generation time). 
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that depends on addition of the siderophorc mycobactin J to pcnnit in-vitro gnm:th on solid 
media, and with a strong tendency to form large clumps (Grant ct al. 2003 ). Studies have 
shown that MAP is a slowly growing mycobacterium. requiring up to 20 weeks. to produce 
colonies on solid medium (Whipple ct al. 199 J ). It is reported that the two properties of 
MAP (slow growth and mycobactin-depcndcnce) arc not linked. Researchers have 
demonstrated that, while the addition of mycobactin J to culture broth pcm1its growth of 
bovine strains of MAP (also called MAP Cow). the ovinc strains (MAP Sheep) arc 
probably not rnycobactin-depcndent (Turennc et al. 2007). MAP isolates could be 
categorized into various clusters. based on growth characteristics and other factors. Many 
authors (Collins et al. 1990: Stevenson et al. 2002: de Juan ct al. 2005: Pavlik ct al. 1999) 
have categorized MAP isolates into into three groups ( types I. I I. and 111) using grov.1h 
characteristics by culture and molecular characterization by PFGL and IS900-RFLP. It is 
reported that Type II MAP strains are considered slow growers that were originally 
described in cattle, followed by isolation from a wide variety of hosts and geographical 
locations, while Types l and III groups are extremely slow growing strains. that were first 
isolated in sheep (Collins et al. 1990) and susequently isolated in few cattle and goats 
(Whittington et al. 2001; de Juan et al. 2005: 2006). Castellanos et al. (2010) reported the 
molecular characterization of A{rcohacterium uvium subspecies paratuherculo.1is Types II 
and III isolates by a combination of MIRlJ-VNTR loci. A study conducted by Stevenson 
et al. (2002) utilized the methods of pulsed-field electrophoresis (PFGE) and IS900-
restriction fragment length polymorphisms. to divide MAP isolates into two distinct types. 
with type I comprising very slow-growing. mostly pigmented isolates forming smooth and 
uniform colonies mainly obtained from sheep and other small ruminants and type 11 
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comprising slow-growing, nonpigmcnted isolates forming rough and nonuniform colonies 
exhibiting a very broad host range. Dohmann and colleagues (2003) reported the 
characterization of genetic differences between .\~rcohacterium a,·ium suhsp. 
paratuberculosis Type I (sheep) and Type II (bO\inc) isolates. They concluded that both 
types of M avium subsp. paratuhercu/osis strains originated from a common progenitor 
(Dohmann et al. 2003 ). 
The growth rate variation of MAP could be the results of many factors. Previous 
authors have shown that many factors may contribute to growth rate variation of 
mycobacterial species, such as genetic differences between strains, sample storage 
conditions, medium difference, and clumping of the mycobactcria (Shin ct al. 2007: 
Lambrecht et al. 1988; Hoal-van Heiden ct al. 200 I). Investigators ( Lambrecht ct al. 1988; 
Hoal-van Heiden et al. 200 I) reported that clumping increases the growth rate of 
mycobacteria both in vitro and m vivo. According to lloal-van Jleldcn et al. (200 I). 
clumping of the mycobacteria resulted in more vigorous growth in human monocyte-
derived macrophages (MDM), suggesting that inoculum size could affect disca-;e 
progression. According to Whipple et al. ( J 987). strain variation may explain why there are 
differences in the progression of disease among herds infected with M. paratuherculosis. 
Shin et al. (2007) reported that MAP subgroup II strains grew faster than subgroup I 
strains, especially at higher inocula (> 103 CFU). They concluded that this growth rate 
difference between laboratory-adapted and low-passage clinical isolates could possibly be 
explained by the genetic differences between strains. by sample storage conditions. or by 
greater clumping at high inocula. Janagama et al. (2010) carried out transcriptional and 
proteomic profiling of MAP strains under iron-replete or -deplete conditions. and reported 
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that iron-sparing response. a phenotypic characteristic of .\~rrnhacteriwn al'ium subsp. 
paratuberculosis, is strain dependent. 
An essential component of cell wall of mycobactcria. and other members of the 
family Corynebacterineae are Jong-chain -alhL and -hvdroxv fattv acids. refercd to as 
"' ,,# "' ~ 
mycolic acids (Brennan and Nikaido. 1995 ). Research has shown that the structure of the 
mycolic alkyl chains is affected by the nature of the carbon source (Sokolovska ct al. ~003: 
Wick et al. 2002). Several studies (Glickman ct al. '.WOO: Liu ct al. 1996: Yuan ct al. 1998: 
Dubnau et al. 2000) have demonstrated that the amounts and composition of mycolic acids 
affect the growth rate, virulence. permeability and colony morphology of Mrcohacteria 
tuberculosis. According to Glickman ct al. (2000). colonial morphology of pathogenic 
bacteria is often associated with virulence. and virulence is correlated with the formation of 
serpentine cords. Glickman et al. (2000) showed that a mycobactcrial gene. pcaA. is 
required for cording and mycolic acid cyclopropane ring synthesis in the cell wall of both 
BCG and M tuberculosis. They further demonstrated that mutants of pcaA fail to persist 
within and kill infected mice despite normal initial replication. Their results indicate that a 
novel member of a family of cyclopropane synthetascs is necessary for lethal chronic 
persistent M tuberculosis infection and define a role for cyclopropanated lipids in bacterial 
pathogenesis. Rao et al. (2006) examined the role of .\~rcohaclerium tuherculosis bioactive 
cell envelope lipids in tuberculosis pathogenesis. Their results showed that trans-
cyclopropanation of mycolic acids on trehalosc dimycolatc (TDM) suppresses 
lvfycobacterium tuherculosis-induced inflammation and virulence. and M. tuherculosis 
mutant lacking trans-cyclopropane rings was hypcrvirulent in mice (Rao ct al. 2006). Riley 
(2006) suggested that the relative composition and structural differences in TDM among 
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different mycobacteria influence the host animal biologic response. TDM is composed of a 
nonreducing sugar trehalose covalently linked to mycolic acids (Riley. 2006). Beaman and 
Moring (1988) reported that the specific composition of C 54 mycolic acids was very 
different in virulent log-phase cells compared v, ith less-virulent stationary-phase cells. and 
the avirulent mutant lacked a C54:3 mycolate that was prominent in the virulent Jog-phase 
parent strain (GUH-2P). These results suggest that certain mycolic acids are associated 
with virulence (Beaman and Moring 1988 ). 
Although previous studies ha\'C characterized MAP based on phenotypic properties 
(e.g growth rate, pigmentation. lipid profile etc.) and molecular assays (e.g. PFGE. JS900 
RFLP, IS1311 PCR-REA, SSR typing. VNTR typing etc.). more studies arc still required 
in order to completely understand the virulence and pathogenicity of MAP organisms. 
The aim of this study was to examine for associations between the biochemical 
variability of MAP strains and their growth rate and presence of symptoms in the source 
cattle. Additionally, to gain a better sense of the pathogenic mechanisms involving MAP in 
Crohn's disease, the present study compared the phenotypic characteristics of MAP strains 
isolated from Crohn · s disease patients with those from cattle with paratubcrculosis. 
Ultimately, the data obtained in this study will help in the future management of animal 
farming operations, and possibly in the future development of vaccines. new drugs and 
treatment methods for Johne·s and Crohn·s disease. 
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MATERIAL AND METHODS 
Bacterial strains, fecal samples and growth condition 
A total of 122 [118 bovine. l sheep and J human (AICC -BOIS. 43544. 49164)1 
MAP isolates were used in this study. The bo\·ine and sheep MAP isolates were obtained 
from the North Dakota State Veterinary Diagnostil'. Laboratory. Fargo. North Dakota. 
while the 3 MAP isolates from Crohn·s disease patients (Arce 43015. 43544. 49164) 
were purchased from the American Type Culture Collection, Manassas. VA. Fecal samples 
of cattle infected with MAP were cultured by modifications of methods described 
elsewhere (Whipple et al. 1991 ). Briefly. the fecal samples were decontaminated with 
0.75% HPC (hexa-decyl-pyridinium chloride: cetylpyridinium chloride) and cultured on 
two Herrold Egg Yolk Media (HEYM) with and without Mycohactin J and incubated at 
37°C. Results were examined weekly for up to I 6 weeks of incubation. Positi\·e cultures 
were confirmed by PCR analysis (IS900) of the gnming colonies. following the protocols 
described previously (Ayele et al. 2005 ). In addition. freezer stocks of MAP isolates 
(ATCC 43015, 43544, 49164) were revived in 71I9 broth (Becton. Dickinson. Sparks. 
Md.). In this study, MAP colonies that appear in :::: 2 weeks wen: classified as rapid 
growers, while those colonies that appear in / 2 weeks were clusten:d as slow growers. 
Bacteria counts 
Preparation of sinyJe-cell swpensions and measure men/ hy v>ectropholometer: A 
single colony of pure mycobacteriurn culture was inoculated into a 5-ml volume of 
Middlebrook broth, and single-cell suspensions of each strain were prepared a-; pre\'iously 
described (Lambrecht et al. 1988 ). with slight modifications. Briefly. mycobacterial cells 
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grown in mycobactin-supplemented Middlebrook 7H9 broth at 3 7°C for 14 16 weeks. 
were harvested by centrifugation at 10.000 x g i<.)r 15 min and washed thrice in IO mM 
phosphate-buffered saline (PBS) (pH 7.2 ). Cell pellets were homogenized by rnrtexing. for 
30 seconds to minimize clumping of cells. Cell pellets were resuspended in PBS and the 
mycobacteria cell suspension was adjusted to a spectrophotometer OD,.w of 1.3 - 1.4. 
Quantification of viahle hacteria. An important foundation from several types of 
microbiological research is the quantification of viable bacteria. The number of viable 
mycobacterial cells in each single-cell suspension was dctem1ined by standard plate 
counting as a reference method. Briefly. one milliliter of the undiluted stock cell 
suspension (00540 of 1.3-1.4) was added to 9.0 ml of IO mM PBS (pll 7.2). Tenfold serial 
dilutions were made in 10 mM PBS (pH 7.2). with vortexing between each dilution step. 
One hundred micro liters from each dilution was plated onto each of three 71110 agar plates 
supplemented with l 0% OADC ( olcic acid-alburnin-dextrose-catalase) and 2 µg/ml of 
mycobactin J. Colony counts (CflJ) were determined after the incubation of plates at 3 7°C 
for 16 weeks. 00540 of 1.3 - 1.4 equates roughly to 3 • 10
9 5 ,, 10'
1 
CFlJ/ml of MAP 
cells. 
GroupinR of isolales according to intensity uf infection. The intensity of infection 
was determined using the colony forming units per tube ((TU/tube). Following 16 weeks 
of incubation, the number of MAP colonies was in the range of 0-200 (TU and were 
grouped as follows: low shedders ( 1-50 (TU/tube) and heavy shcdders (greater than 50 
CFU/tube). 
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Mass spectrometry analysis 
Extraction and derimti::ation of mycolic acids. MAP cell wall mycolic acid was 
extracted and esterified by use of protocol previously described by Minnikin ct al. ( 1980). 
In brief, one-milliliter aliquot of the bacterial culture (0D 540 of 1.3 · 1.4 that corresponds 
to 3 x 109 - 5 x 109 CFU/ml of cells) was transferred to a new tube and centrifuged at 3.500 
x g for 20 min. The cell pellets were cstcriticd by mixing with 2 mls of transcstcrification 
reagent, methanol/toluene/1-bSO.t in the ratio of 30: I 5: I. The samples were heated at 85°C 
for 16-18 hours in an oil bath. Then. 2mls of chlorofonn: hexane (4:1) was added to the 
cooled sample. This was followed by addition of I ml of O.J M phosphate buffer (42.57 g 
of Na2HP04 and 12.0 g of NaOI I per liter of distilled \\ater (pl I 11 to I 2 ). Samples \\ere 
centrifuged (3,000 x g, 10 min. 4°C ). and the lower organic layer containing the fatty acid 
was transferred to a clean tube. The extracts were evaporated to dryness under a stream of 
nitrogen at 37-42°C and stored at 0°C. 
Analysis o.f methyl mycola1es hy mass spec1rome1ry The puri lied mcthy I mycolates 
were analysed using BioTOF Elcctrospray Ionization Time-of-Flight (ESJ-TOF) Mass 
Spectrometer, associated with Bruker Daltonic Data Analysis ( Bruker Daltonics HiolOF 
Billerica, MA USA). About 10 mg of the mycolic acid methyl esters were dissolved in 2 
ml of methanol and serially diluted to a I µM concentration and 10 µl of the solution was 
injected into the mass spectrometer. Lach sample was analyzed three times with identical 
results. 
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Statistical analysis 
The results of the present stud:, \\ere analyzed as desnihed hy Niemann et al. 
(1999). Data were analyzed with the use of software package CDCs Epi Info program 
(version 3.5.1 ). Chi-square and logistic regression were used to analyze !l)r associations 
between the biochemical and genetic variability of MAP strains and their growth rate or 
presence of symptoms in source cattle. 
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RESULTS 
Table 5.1 shows the relationships between growth rate status (rapid or slow) of 
MAP infected cattle and other \'ariables ( PHiF pro tiles of isolates. mass spectrometry 
patterns of isolates, shedder status of animals and symptom status of animals). 
Table 5.1: Univariate logistic regression analysis of associations hetween growth rate 
(slow or rapid) status of MAP infected cattle and other, ariable factors (mass spectrometry 
patterns of isolates (OR== 4.4. 95% Cl =- 2.0. 9.8). symptom status (OR · 11.0. 95% Cl== 
4.5, 26.8) and shedder status (OR= 2.6. 95% Cl cc. 1.2. 5.4). 
------ -------- ---- -- - -- -- - - -----------·-~ 
Variable Category No of Pen.:ent Percent df P \'alue 
isolates slo\, rapid 
growers grovvers 
(<Yo) (%) 
--------------- - ·------ ---- - -----------
Mass Ml 47 68.1 31.9 0.00014 
spectrometry M2 71 32.4 67.6 
Patterns 
---·-------~ ·-------- -
--- -----·---- -- ------
Symptoms Asymptomatic 66 69.7 30.J -0.00001 
Symptomatic 52 17.3 82.7 
-------------- -- -
--- "- .. ----- -------- - --- ·- -------·-
Shedder Low shedder 65 56.9 43.1 0.012 
status High shedder 53 34.0 66.0 
----------- -
------ ·--------- -- --- - -·-------
Figures 5.1-5.6 show examples of the results of the mass spectral analysis of slow 
and rapid growing bovine MAP isolates. \\,hich were classifit:d into two groups: MI and 
M2 based on the differences in carbon chain lengths. with Ml groups ha\·ing short carbon 
lengths, and M2 groups having long carbon chain lengths. 
Figures 5.7 shows the mass spectral result of the sheep MAP isolate. 
Figures 5.8-5. IO shows the mass spectral results of the three human clinical isolates 
(ATCC 43015, 43544, 49164)]. 
Figure 5.11 shows the bar chart representing the sources of slow and rapid growing 
Mycobacterum avium subspecies paratuhercu/osi.1 isolates ( cattle. humans and sheep) and 
the percentage of mass spectra group (MI or M2) belonging to each source. 
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Figure 5.1: Mass spectral analysis of MAP isolate which was slow growing and belong m 
the Ml group. 
Figure 5.12 shows the relationship between the growth rate of bovine MAP i olate 
and their shedder and symptom status. There is a significant difference between low 
growers and rapid growers of MAP strains. Each bar repre ents the percent of MAP 
isolates belonging to each category: shedder status (low and high) and symptoms status 
(symptoms or no symptoms). 
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Figure 5.2: Mass spectral analysis of a bovine MAP isolate which was low growing and 
belongs in the Ml group. 
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Figure 5.3: Mass spectral analysis of a bovine MAP isolate, which was slow growing and 
belongs in the Ml group. 
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Figure 5.4: Mass spectral analysis of a bovine MAP i olate, which was rapid growing and 
belongs in the M2 group. 
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Figure 5.5: Mass spectral analysis of a bovine MAP isolate which was rapid growing and 
belongs in the M2 group. 
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Figure 5.6: Mass spectral analysis of a bovine MAP isolate which was rapid growing and 
belongs in the M2 group. 
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Figure 5.7: Mass spectral analysis of a sheep MAP isolate which was low growing and 
belongs in the MCl group. 
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Figure 5.8: Mass spectral analysis of human MAP isolate, AT 
growing and belongs in the MC2 group. 
185 
. 
,..15 
M • ' 
900 1000 1100 ""1 
43015 which was rapid 
lntens. 
x1 o4 
386.3 
3 
360.3 
2 
429.3 
473 .3 
1 
297 .2 
517.3 
561 3 
605 3 
IL 
649 4 7~ 6 
~ • 
.I ~ L I IL L ull1 lull , ,1 l 11 ~11 1, 0 . 
--. 800 300 400 500 600 700 
Figure 5.9: Mass spectral analysis of human MAP isolate, AT 
growing and belongs in the MC2 group. 
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Figure 5.10: Mass spectral analysis of human MAP isolate, AT C 49164, which was slow 
growing and belongs in the MC 1 group. 
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Figure 5.11 : Bar chart representing the sources of slow and rapid growing MAP i olate 
( cattle, humans and sheep) and the percentage of mass spectra group belonging to e ch 
source origin. 
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Figure 5.12: Bar chart of the relation hip between growth rate of MAP i olate and the 
shedder and symptom status of the isolates. 
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DISCUSSION 
The present study has examined the biochemical variability of rapid and slow 
growing MAP strains. Table 5.1 shows the associations between growth rate status (rapid 
or slow) of MAP infected cattle and other \ariablc factors (mass spectrometry patterns of 
isolates, shedder status of animals and symptom status of animals). In the statistical 
analysis, the MAP growth rate was used as the outcome \ariahlc. Our protocol classifies 
an isolate as a rapid or slow grower based on whether thi: isolak took less ( < ) or more than 
(>) two weeks, respectively. to appear. 
In this study, we investigated the relationships between gnw:th rate and the cell 
wall lipid of MAP isolates, by use of mass spectromi:try analysis of mycolic acid. The 
mass spectrometry results demonstrated yield peaks ranging from m/z 271 to 1200. We 
observed that some MAP isolates yielded only peaks with short carbon chain lengths (ions 
ranging from m/z 271 to 900). and our protocol categorized them as MI pattern MAP 
group, while some other MAP isolates produced peaks with hoth short and long carbon 
chain length (ions ranging from m/z 271 to 1200 ). and these were classi lied as M2 pattern 
MAP group. Chi square analysis of our data rC\ealcd a significant difference (p = 0.00014) 
between mass spectrometry patterns and growth rate of isolates. We observed that the 
majority (68. l % ) of slow growers produced a series of short chain carbon lengths mycolic 
acid (Ml pattern), compared to 31.9 % of slow growers. Likewise. most (67.6%) of rapids 
growers produced a series of long and short chain carbon lengths mycolic acid (M2 
pattern), compared to 32.4 % of slow growers. Univariate logistic regression showed that 
short carbon chain length mycolic acid was significantly associated with slow grcmth rate. 
while increase in carbon chain lengths was associated with rapid growth rate (OR~ 4.5. 
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95% CI= 2.0, 9.8; p = 0.000 I). These findings suggest that <.:hanges in <.:ell wall 
composition, especially the presence of long <.:arbon lengths mycolic acid <.:ould atle<.:t the 
rate of growth of MAP bacteria. which in turn wuld affect disease progression. 
Our results bear very close resemblance to those of previous studies (Laval ct al 
2001), where the chain lengths of the mycolates <.:0rrclated with the grow1h rate of 
mycobacterium isolates. Laval and colleagues c:iool) analyzed mycolic acids. major and 
specific long-chain fatty (C70-C90) acid components of the myrnba<.:terial cell envelope, 
using matrix-assisted laser desorption/ionization time-of-flight ( MALDI-TOF) mass 
spectrometry. Their results showed that the chain lengths of the various mycolates 
correlated with the growth rate of my<.:ohacterial strains. v,:ith slow growers. such as 
Mycobacterium tuberculosis and A{vcohacterium ulcerans. producing a series of odd 
carbon numbers (C74-C82) of alpha-mycolic acids. and rapid growers synthesizing both 
odd and even carbon numbers. Additionally their results show that the main chain of 
oxygenated mycolic acids from slow growers were four to six <.:arhon atoms longer than 
the corresponding alpha-mycolic acids. whereas rapid growers elaborated oxygenated 
homologues possessing the same chain lengths as their alpha-mycolic acids (Laval et al. 
2001). Our data are also in agreement with those of previous investigators (Daffr and 
Draper, 1998; Brennan and Nikaido. 1995) that reported that the composition and amount 
of mycolic acids affect the grow1h rate. colony morphology and permeability and virulence 
of M tuberculosis. 
In addition, the present study observed a significant difference (P == 0.012) between 
growth rate and symptom manifestation with 82.7 % of rapid MAP growers causing 
symptoms in source cattle compared to only 17.3 % of slow growers. Also. univariate 
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logistic regression showed a significant association between growth rate and presence of 
symptoms in source cattle (OR=l 1.0. 95% CJ= 4.5. 26.8: p <(J.0001 ). between grov.1h rate 
and shedder status (OR= 2.6. 95% Cl = 1.2. 5.4). as well as between growth rate and 
presence oflong chain length mycolic acid (M2) (OR= 4.4. 95% CI~ 2.0. 9.8: p = 0.0002). 
Additionally, while 69.7% of slow growing MAP isolates wen: found in asymptomatic 
cattle, only 30.3% of rapid growers were found in asymptomatic cattle. 
The association between long chain rnycolic acid. rapid growth rate and presence of 
symptoms in cattle partly suggests that the genetic ditkn:nces hetween strains could 
possibly be a reason for differences in growth rate. virulence. pathogenesis and progression 
of disease among MAP infected cattle. Our results are in agreement to those of previous 
studies (Whipple et al. 1987). According to Whipple et al. ( I 987). strain variation may 
explain why there are differences in the progression of disease among herds infected with 
M paratuberculosis. Lewin and Sharbati-Tchrani (2005) reported that growth rate of 
mycobacteria is associated with pathogenicity. and slowcr-grm,.1h is related to greater 
pathogenicity. Valway et al. ( J 998) demonstrated that a strain of A1ycohacJerium 
tuberculosis (CDC] 55) have a greatly faster doubling time in the lungs of mice than the 
long established Erdman strain. Based on this finding. it was reasoned that strain CDC I 55 I 
has a very high virulence for mice and that this could indicate that it ha~ a high virulence 
for humans, which in tum, would further explain its unusually high transmissihility. 
In contrast to our results, some studies show that gro~1h rate is not an indicator of 
virulence. Thus, while some studies have associated the grcm1h rate of mycobactcria with 
pathogenicity (Whipple et al. I 987: Lewin and Sharbati-Tchrani. 2005: Valv,:ay ct al. 
1998), some other studies have rejected this idea (North ct al. I 999 ). North ct al. (1999) 
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investigated whether the ability of .\f. ruhl!rculosis CDC 1551 to multiply in the lungs of 
mice over a relatively short period of obsen atiDn was associated with the ability to cause 
disease, and reported that the growth rate of rnycobacteria in mice as an unreliable 
indicator of mycobacterial virulence. 
In addition, in the present study. to obtain insights into the the association between 
Johne's and Crohn's disease. we in\'estigated if the strains of MAP isolated from Crohn·s 
disease could share similar phcnotypic characteristics with those involved in Johnes 
disease. We observed that all the human MAP isolates possessed the MS2 mass 
spectrometry pattern. Furthermore. the mass spectrometry patterns of the sheep MAP 
isolate were similar to those of bovine MAP strains. and he longed to the group MS I. The 
similarities in the mass spectrometry patterns of bovine. sheep and human MAP isolates 
could possibly explain the theory of strain sharing. intra-species and interspecies 
transmission, and particularly. the similarity between bovine and human MAP isolates may 
further support an association between johnnc·s disease and Crohn·s disease. Scanu ct al. 
(2007) reported that MAP is a candidate pathogen in the causation of a proportion of cases 
of irritable bowel syndrome as well as in Crohn's disease. These researchers reported a 
significant association (P 0.0018) between . \fvcohucterium a\'1um suhsp . 
paratuberculosis infection and the consumption of hand-made cheese (Scanu ct al. 2007). 
According to Motiwala et al. (2006 ). evidence of strain sharing between ho vine and human 
MAP isolates is of special interest since it implies the existence of a potential animal 
reservoir for Crohn's disease. 
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CONCLUSION 
By using mass spectrometry, we were able to detect biochemical differences among 
one hundred and twenty-two [ 118 bovine strains of MAP belonging to two groups (rapid 
and slow growers), 3 human (ATCC 43015. 43544. 49164). and I sheep] isolates. Based 
on the similarities between bovine. sheep and human MAP isolates. the present study is 
considered to support the hypothesis of interspecies ( c .g from sheep to cattle. cattle to 
sheep or cattle to humans), and intraspccies transmission (from cattle to cattle or sheep to 
sheep). Our data could further support an association between Johne·s disease and Crohn·s 
disease, based on similarities in bim:hcmical profiles between bovine and human MAP 
isolates. Overall, the present study has provided a better understanding of some factors that 
may influence the bacteria growth rate (c.g lipid profiles). as well as the association 
between Johne's and Crohn·s disease. Our study has shed more light on MAP biochemical 
features, and should fuel new developments in the control and treatment of Johnc·s and 
Crohn's disease. Future studies should include the identification of other bacterial and non-
bacterial factors that may influence bacterial gro\\1h rate and also affect <lisea'ie 
progression in MAP infected animals and humans. 
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PAPER6 
EVALUATION OF MYCOBACTERIUM A VIUM 
SUBSPECIES PARATUBERCULOSJS STRAINS HAVING 
DIFFERENT SHEDDING CHARACTERISTICS 
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ABSTRACT 
Background: Mycobacterium arium subspecies paratuherrnlosis (MAP) is bacteria 
pathogen that causes paratuberculosis. also knO\vn as Johne ·s disease. a chronic 
inflammatory disease of the intestine of ruminant animals. and is suggested 10 play a causal 
role in human Crohn's disease. However. this theory is still controversial. Previous works 
have shown that differences in cattle shedding levels existed among culture-positive MAP 
strains. Objectives: The goal of the present study was to evaluate associations between the 
shedding levels of MAP isolates and other factors. such as phenotypic features (c.g lipid 
profiles of isolates, growth rate of isolates. symptom status of source cattle and farm 
sources of isolates). Methods: The technique of mass spectrometry was used to analyze 
MAP isolates (n= 121) from cattle with different shedding status. MAP isolates were 
classified as low shedder isolates if there arc < 50 CFU/tubc and heavy shcddcr isolates if 
there are > 50 CFU/tube. Statistical analysis was done using Epi Infrl version 3.5. I. The 
shedder status of isolates was used as the outcome variable. Results: Univariate logistic 
regression analysis showed that the shedder status of isolates was significantly associated 
with growth rate of isolates, symptom status. and source regions. hut not with mass spectra 
patterns of isolates. Conclusion: In general. the results of this study provided more insight 
into the biochemical diversity among MAP isolates from low and high shcdder host cattle. 
which may be useful in the management of animal farms and in future evaluation of 
vaccines, diagnostics and therapeutics for paratubcrculosis and possibly Crohn·s disea~c. 
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INTRODUCTION 
Mycobacterium avium subspecies paratuherculosis (MAP). is an acid-fast 
bacterium and the causative agent of paratuberculosis. also known as Johm~·s disease. a 
chronic gastroenteritis mainly affecting cattle and other ruminants ( Chiodini ct al. 1984: 
Sweeney et al. 1996), and widely distributed in different parts of the world ( Kennedy and 
Benedictus, 2001 ). Animals with paratubcrculosis shed viable MAP in their faeces and 
milk (Ellingson et al. 2005). Fecal shedding of MAP occurs in the absence and presence of 
clinical signs of disease. It is reported that both subclinically and clinically affected cows 
can shed off fecal material thus contaminating the environment and spreading the infection 
to newborn calves by fecal-oral route (Sweeney et al. 1996 ). Subclinical carriers excrete 
variable numbers of MAP in the feces. In most cases. large numbers of organisms arc 
excreted as clinical disease develops. Studies show that MAP survives for long periods in 
the environment (Whittington et al. 2004: Rowe and Grant. 2006). According to Pavlik ct 
al. (1999), the rapid spread of Johne's disease is caused by the trnde in subclinically 
infected animals and infection in early calfhood. 
Previous works have shown that differences in MAP shedding levels existed among 
culture-positive cattle and that the higher the numbers of MAP colonies detected by 
culture, the greater the risk of spread of the disease. Fecal culture is considered the gold-
standard of diagnosis of MAP infection in cattle. with fecal-positive individuals classified 
as low shedder (I-9 CFU/tube), moderate shedders (10-50 (TU/tube) or heavy shcddcrs 
(greater than 50 CFU/tube) (Crossley et al. 2005). According to Whitlock ct al. (2005). 
cattle are classified as low, moderate or high shcdders based on the visible colonies of 
MAP on the surface of solid media. specifically. Herrold's egg yolk media (HEYM). 
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